Umemura Takeji
Academic Assembly School of Medicine and Health Sciences Institute of Medicine
School of Medicine Department of Medicine
Professor
Researcher Information
Research Keyword
- HLA, Liver cancer, Viral Hepatitis, KIR
Field Of Study
Web site
Research activity information
Award
- 2015
鈴木謙三記念医科学応用研究財団研究助成
International academic award - 2015
加藤記念難病研究助成基金
International academic award - 2008
信州大学医学部松医会賞臨床部門
International academic award - 2007
膵臓病研究財団研究助成
International academic award - 2007
信州大学若手萌芽研究助成
International academic award - 2006
日本肝臓学会第5回 Schering-Plough-Award
International academic award - 2006
日本消化器病学会研究助成
International academic award - 2005
ウイルス肝炎研究財団研究助成
International academic award
Paper
- Letter: Filling the Gaps-Enhancing MASLD Prognosis With Imaging, Diverse Populations and Extended Follow-Up. Authors' Reply.
Nobuharu Tamaki; Takefumi Kimura; Shun-Ichi Wakabayashi; Takeji Umemura; Namiki Izumi; Rohit Loomba; Masayuki Kurosaki
Alimentary pharmacology & therapeutics, Oct. 2024
Lead
- Circulating thrombospondin 2 as a predictor of hepatocellular carcinoma in hepatitis B patients undergoing nucleos(t)ide analog therapy.
Taiki Okumura; Takefumi Kimura; Yuki Ichikawa; Takanobu Iwadare; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Takuro Uchida; Sai P Pydi; Naoki Tanaka; Takeji Umemura
Scientific reports, 14(1), 25584-25584, Oct. 2024
Lead - Serum Autotaxin Levels Predict Liver-Related Events in Primary Biliary Cholangitis Patients: A Long-term Multicenter Observational Study: Autotaxin predict liver-related events in PBC.
Takanobu Iwadare; Takefumi Kimura; Yuki Yamashita; Taiki Okumura; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Ayumi Sugiura; Tomoo Yamazaki; Satoshi Shimamoto; Koji Igarashi; Satoru Joshita; Takeji Umemura
Clinical and translational gastroenterology, Oct. 2024
Lead - Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy.
Takanobu Iwadare; Takefumi Kimura; Ayumi Sugiura; Taiki Okumura; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Tomoo Yamazaki; Satoru Joshita; Naoki Tanaka; Takeji Umemura
Journal of viral hepatitis, Oct. 2024
Lead - Endoscopic assessment of minor papilla morphology: Predictors of successful cannulation and procedural pancreatitis risk in minor papilla endotherapy
Yasuhiro Kuraishi; Akira Nakamura; Shohei Kondo; Takumi Yanagisawa; Ichitaro Horiuchi; Masafumi Minamisawa; Nobukazu Sasaki; Yugo Iwaya; Tadanobu Nagaya; Takeji Umemura
Journal of Hepato-Biliary-Pancreatic Sciences, Sep. 2024, Refereed
Last - Editorial: Cardiometabolic criteria matters in MASLD-Authors' reply.
Nobuharu Tamaki; Takefumi Kimura; Shun-Ichi Wakabayashi; Takeji Umemura; Namiki Izumi; Rohit Loomba; Masayuki Kurosaki
Alimentary pharmacology & therapeutics, Sep. 2024
Lead - Hepatitis B surface antigen glycan isomer as a new potential biomarker in patients with hepatitis B virus infection.
Taiki Okumura; Takeji Umemura
Hepatology research : the official journal of the Japan Society of Hepatology, Aug. 2024
Lead - Cardiometabolic criteria as predictors and treatment targets of liver-related events and cardiovascular events in metabolic dysfunction-associated steatotic liver disease.
Nobuharu Tamaki; Takefumi Kimura; Shun-Ichi Wakabayashi; Takeji Umemura; Namiki Izumi; Rohit Loomba; Masayuki Kurosaki
Alimentary pharmacology & therapeutics, Aug. 2024
Lead - Glycemic control target for liver and cardiovascular events risk in metabolic dysfunction-associated steatotic liver disease.
Nobuharu Tamaki; Shun-Ichi Wakabayashi; Takefumi Kimura; Yutaka Yasui; Kaoru Tsuchiya; Hiroyuki Nakanishi; Daniel Q Huang; Takeji Umemura; Masayuki Kurosaki; Namiki Izumi
Hepatology research : the official journal of the Japan Society of Hepatology, 54(8), 753-762, Aug. 2024
Lead - Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study.
Ayaka Tanifuji; Satoko Ohfuji; Kosuke Matsumoto; Masanori Abe; Atsumasa Komori; Atsushi Takahashi; Kazuhito Kawata; Ken Sato; Satoru Joshita; Takeji Umemura; Masayuki Ueno; Nobuaki Nakayama; Keisuke Kakisaka; Teruko Arinaga-Hino; Koichi Ito; Sachiko Kanai; Ryo Miura; Toshihiko Arizumi; Yoshinari Asaoka; Takanori Ito; Tetsuya Shimizu; Hiroshi Yoshida; Masayuki Ohta; Suguru Mizuno; Hiroyuki Isayama; Youichi Morimoto; Satoshi Mochida; Hiromasa Ohira; Atsushi Tanaka
Hepatology research : the official journal of the Japan Society of Hepatology, 54(7), 706-715, Jul. 2024
Lead - Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation.
Haruki Uojima; Kazumi Yamasaki; Masaya Sugiyama; Masayoshi Kage; Norihiro Ishii; Ken Shirabe; Hisashi Hidaka; Chika Kusano; Miyako Murakawa; Yasuhiro Asahina; Takashi Nishimura; Hiroko Iijima; Kazumasa Sakamoto; Kiyoaki Ito; Keisuke Amano; Takumi Kawaguchi; Nobuharu Tamaki; Masayuki Kurosaki; Takanori Suzuki; Kentaro Matsuura; Akinobu Taketomi; Satoru Joshita; Takeji Umemura; Sohji Nishina; Keisuke Hino; Hidenori Toyoda; Hiroshi Yatsuhashi; Masashi Mizokami
Journal of gastroenterology, 59(7), 598-608, Jul. 2024
Lead - Long-term clinical outcomes in steatotic liver disease and incidence of liver-related events, cardiovascular events and all-cause mortality.
Nobuharu Tamaki; Takefumi Kimura; Shun-Ichi Wakabayashi; Takeji Umemura; Masayuki Kurosaki; Rohit Loomba; Namiki Izumi
Alimentary pharmacology & therapeutics, 60(1), 61-69, Jul. 2024
Lead - Editorial: Has MetALD met the presumption? Authors' reply.
Nobuharu Tamaki; Takefumi Kimura; Shun-Ichi Wakabayashi; Takeji Umemura; Namiki Izumi; Rohit Loomba; Masayuki Kurosaki
Alimentary pharmacology & therapeutics, 60(1), 99-100, Jul. 2024
Lead - Leucine-rich repeat-containing G protein-coupled receptor 5 expression in lymph node metastases of colorectal cancer: Clinicopathological insights and prognostic implications.
Hiroshi Sawaguchi; Takeshi Uehara; Mai Iwaya; Shiho Asaka; Tomoyuki Nakajima; Masato Kamakura; Tadanobu Nagaya; Takahiro Yoshizawa; Hiroyoshi Ota; Takeji Umemura
Pathology international, 74(7), 387-393, Jul. 2024
Lead - Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease.
Shun-Ichi Wakabayashi; Nobuharu Tamaki; Takefumi Kimura; Takeji Umemura; Masayuki Kurosaki; Namiki Izumi
Journal of gastroenterology, 59(6), 494-503, Jun. 2024
Lead - Case of severe alcoholic hepatitis following acute pancreatitis.
Takeru Yokoyama; Takanobu Iwadare; Yuki Yamashita; Akari Momose; Hiroshi Ikeuchi; Shohei Kondo; Kenta Hashigami; Mai Iwaya; Takefumi Kimura; Takeji Umemura
Clinical journal of gastroenterology, May 2024
Lead - Serum Leucine-Rich α2 Glycoprotein Could Be a Useful Biomarker to Differentiate Patients with Normal Colonic Mucosa from Those with Inflammatory Bowel Disease or Other Forms of Colitis.
Ichitaro Horiuchi; Kaori Horiuchi; Akira Horiuchi; Takeji Umemura
Journal of clinical medicine, 13(10), May 2024
Lead - Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan.
Tetsuya Takikawa; Kazuhiro Kikuta; Takanori Sano; Tsukasa Ikeura; Nao Fujimori; Takeji Umemura; Itaru Naitoh; Hiroshi Nakase; Hiroyuki Isayama; Atsushi Kanno; Ken Kamata; Yuzo Kodama; Dai Inoue; Akio Ido; Toshiharu Ueki; Hiroshi Seno; Hiroaki Yasuda; Eisuke Iwasaki; Takayoshi Nishino; Kensuke Kubota; Toshihiko Arizumi; Atsushi Tanaka; Kazushige Uchida; Ryotaro Matsumoto; Shin Hamada; Seiji Nakamura; Kazuichi Okazaki; Yoshifumi Takeyama; Atsushi Masamune
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 24(3), 335-342, May 2024
Lead - Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease.
Takanobu Iwadare; Takefumi Kimura; Taiki Okumura; Shun-Ichi Wakabayashi; Taro Nakajima; Shohei Kondo; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Naoyuki Fujimori; Tomoo Yamazaki; Hideo Kunimoto; Satoshi Shimamoto; Koji Igarashi; Satoru Joshita; Naoki Tanaka; Takeji Umemura
Communications medicine, 4(1), 73-73, Apr. 2024
Lead - Association between endoscopic evidence of bile reflux and Barrett's esophagus: A large-scale case-control study.
Yugo Iwaya; Kenichi Goda; Satoko Kako; Honoka Hattori; Takayuki Miyazawa; Daichi Hara; Kenta Hashigami; Atsuhiro Hirayama; Takuma Okamura; Tadanobu Nagaya; Takeji Umemura
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 56(4), 622-627, Apr. 2024
Lead - Predictive Insights Into Exocrine Pancreatic Insufficiency in Chronic Pancreatitis and Autoimmune Pancreatitis: A Decision Tree Approach.
Tomoyuki Tanaka; Takefumi Kimura; Shun-Ichi Wakabayashi; Takuma Okamura; Shohei Shigeto; Naoki Tanaka; Shohei Kondo; Ichitaro Horiuchi; Yasuhiro Kuraishi; Akira Nakamura; Norihiro Ashihara; Keita Kanai; Tadanobu Nagaya; Takayuki Watanabe; Takeji Umemura
Pancreas, 53(3), e227-e232, Mar. 2024
Lead - Thrombospondin 2 is a key determinant of fibrogenesis in non-alcoholic fatty liver disease.
Takefumi Kimura; Takanobu Iwadare; Shun-Ichi Wakabayashi; Seema Kuldeep; Tomoyuki Nakajima; Tomoo Yamazaki; Daiki Aomura; Hamim Zafar; Mai Iwaya; Satoru Joshita; Takeshi Uehara; Sai P Pydi; Naoki Tanaka; Takeji Umemura
Liver international : official journal of the International Association for the Study of the Liver, 44(2), 483-496, Feb. 2024
Lead - Juvenile polyposis syndrome with gastric and duodenal polyposis presenting with refractory anemia and protein-leakage gastroenteropathy in a patient with SMAD4 mutation: a case report.
Kenya Nakamura; Koji Kubota; Akira Shimizu; Tsuyoshi Notake; Tomohiko Ikehara; Kentaro Umemura; Atsushi Kamachi; Takamune Goto; Hidenori Tomida; Yoshiyuki Takahashi; Tadanobu Nagaya; Takeji Umemura; Yuji Soejima
Surgical case reports, 10(1), 11-11, Jan. 2024
Lead - Mucosal damage in pancreaticobiliary maljunction is stronger in the gallbladder than in the bile duct.
Masato Kamakura; Takeshi Uehara; Takashi Muraki; Mai Iwaya; Shiho Asaka; Tomoyuki Nakajima; Yugo Iwaya; Tadanobu Nagaya; Takahiro Yoshizawa; Akira Shimizu; Yasuhiro Kuraishi; Hiroyoshi Ota; Takeji Umemura
Pathology, research and practice, 253, 155011-155011, Jan. 2024
Lead - Detection Rates of Hepatitis B Surface and Core-related Antigens Using Novel Highly Sensitive Assays in Chronic Hepatitis B Patients With Hepatitis B Surface Antigen Seroclearance
Taiki Okumura; Satoru Joshita; Yoshiyuki Kitamura; Haruka Sagi; Takeji Umemura
Gastro Hep Advances, 3(7), 885-887, 2024, Refereed
Lead - Relationship between Helicobacter pylori Eradication and Barrett's Esophagus Elongation.
Kenta Hashigami; Yugo Iwaya; Tadanobu Nagaya; Daichi Hara; Atsuhiro Hirayama; Takuma Okamura; Taiji Akamatsu; Takeji Umemura
Digestion, 105(3), 186-191, 2024
Lead - Diagnosis by combination of endoscopic findings helps differentiate non-Helicobacter pylori Helicobacter-infected gastritis from Helicobacter pylori-infected gastritis.
Takuma Okamura; Yugo Iwaya; Tadanobu Nagaya; Kazuki Horiuchi; Tatsuya Negishi; Hiroyoshi Ota; Takeji Umemura
Helicobacter, 29(2), e13070, 2024
Lead - Long-Term pemafibrate treatment exhibits limited impact on body fat mass in patients with hypertriglyceridemia accompanying NAFLD.
Takanobu Iwadare; Takefumi Kimura; Hideo Kunimoto; Taiki Okumura; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Naoki Tanaka; Takeji Umemura
Frontiers in endocrinology, 15, 1329294-1329294, 2024
Lead - New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease.
Haruki Uojima; Kadzuki Nakabayashi; Kazumi Yamasaki; Masaya Sugiyama; Norihiro Ishii; Ken Shirabe; Takuya Kyoutou; Koji Ueda; Yoichi Takahama; Nobuharu Tamaki; Masayuki Kurosaki; Hisashi Hidaka; Chika Kusano; Keisuke Amano; Takumi Kawaguchi; Akinobu Taketomi; Satoru Joshita; Takeji Umemura; Miyako Murakawa; Yasuhiro Asahina; Takanori Suzuki; Kentaro Matsuura; Takashi Nishimura; Hiroko Iijima; Kazumasa Sakamoto; Kiyoaki Ito; Sohji Nishina; Keisuke Hino; Hidenori Toyoda; Hiroshi Yatsuhashi; Masayoshi Kage; Masashi Mizokami
Journal of gastroenterology, 58(12), 1252-1260, Dec. 2023
Lead - Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study.
Taiki Okumura; Takefumi Kimura; Takanobu Iwadare; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Satoru Joshita; Naoyuki Fujimori; Hideo Kunimoto; Michiharu Komatsu; Hideki Fukushima; Hiromitsu Mori; Takeji Umemura
Cancers, 15(22), Nov. 2023
Lead - Pyogenic liver abscess associated with Klebsiella oxytoca: Mimicking invasive liver abscess syndrome.
Takanobu Iwadare; Takefumi Kimura; Ayumi Sugiura; Risa Takei; Masato Kamakura; Shun-Ichi Wakabayashi; Taiki Okumura; Daichi Hara; Akira Nakamura; Takeji Umemura
Heliyon, 9(11), e21537, Nov. 2023
Lead - Update on respiratory lesions in patients with IgG4-related autoimmune pancreatitis.
Satoshi Kawakami; Hiroshi Yamamoto; Masamichi Komatsu; Keisuke Todoroki; Akira Nakamura; Takaya Oguchi; Takeshi Uehara; Takeji Umemura; Yasunari Fujinaga
Medicine, 102(36), e35089, Sep. 2023
Lead - Kinetics of serum O-glycosylated M-hepatitis B surface antigen with hepatocellular carcinoma history and nucleos(t)ide analogue therapy in hepatitis B patients.
Taiki Okumura; Satoru Joshita; Takanobu Iwadare; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Takefumi Kimura; Takeji Umemura
Journal of viral hepatitis, 30(9), 731-739, Sep. 2023
Lead - HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population.
Taiki Okumura; Satoru Joshita; Tomoo Yamazaki; Takanobu Iwadare; Shun-Ichi Wakabayashi; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Takefumi Kimura; Masao Ota; Takeji Umemura
Human immunology, 84(8), 401-407, Aug. 2023
Lead - Symptom-based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease.
Shun-Ichi Wakabayashi; Satoru Joshita; Kazuhiro Kimura; Hirohiko Motoki; Taiki Okumura; Hiroyuki Kobayashi; Yuki Yamashita; Ayumi Sugiura; Tomoo Yamazaki; Takefumi Kimura; Koichiro Kuwahara; Takeji Umemura
JGH open : an open access journal of gastroenterology and hepatology, 7(8), 527-536, Aug. 2023
Lead - A case of malignant peritoneal mesothelioma with a Fitz-Hugh-Curtis syndrome-like imaging finding.
Takanobu Iwadare; Takefumi Kimura; Yusuke Nagata; Hiroshi Suzuki; Hideo Kunimoto; Hiroyuki Kitabatake; Ayako Seki; Yasuhide Ochi; Etsuo Hara; Takeji Umemura
Clinical journal of gastroenterology, 16(3), 372-376, Jun. 2023
Lead - Immune thrombocytopenic purpura in primary biliary cholangitis and localized cutaneous systemic sclerosis: case report and literature review.
Taiki Okumura; Takefumi Kimura; Yu Hihara; Katsuaki Inoue; Atsushi Maruyama; Satoru Joshita; Takeji Umemura
Clinical journal of gastroenterology, 16(3), 432-437, Jun. 2023
Lead - Real-World Epidemiology, Clinical and Economic Burden of Chronic Hepatitis B in Japan: A Retrospective Study Using JMDC Claims Database.
Takeji Umemura; Kittima Wattanakamolkul; Yoshikazu Nakayama; Yasushi Takahashi; Urbano Sbarigia; Lim KyungHwa; Angelina Villasis-Keever; Martina Furegato; Laurène Gautier; Gregoire Nowacki; Jessica Azzi; David Bin-Chia Wu
Infectious diseases and therapy, 12(5), 1337-1349, May 2023
Lead - Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis.
Yuki Yamashita; Takeji Umemura; Takefumi Kimura; Satoru Joshita; Junko Hirohara; Toshiaki Nakano; Atsumasa Komori; Atsushi Tanaka
JHEP reports : innovation in hepatology, 5(4), 100662-100662, Apr. 2023
Lead - A Diagnostic Impact of Serum Autotaxin Levels in Patients with Bone Marrow Fibrosis.
Hideyuki Nakazawa; Hiroko Kaiume; Koji Igarashi; Tomoo Yamazaki; Takeji Umemura; Naoko Asano; Takeshi Uehara; Fumihiro Ishida
Clinical lymphoma, myeloma & leukemia, 23(2), e117-e124, Feb. 2023
Lead - Splenic artery pseudoaneurysm resulting from gastric ulcer presenting acute upper gastrointestinal bleeding.
Taiki Okumura; Takefumi Kimura; Daichi Nakajima; Shohei Kondo; Satoko Kako; Yoshiyuki Takahashi; Kosuke Yamaka; Fumihito Ichinohe; Yoshinori Tsukahara; Tadanobu Nagaya; Takeji Umemura
Radiology case reports, 18(1), 97-99, Jan. 2023
Lead - Management of Rare Hemorrhage From Collateral Vessels During Gastrostomy Replacement Using Percutaneous Transhepatic Occlusion in Patient With Portal Hypertension.
Taiki Okumura; Takefumi Kimura; Tomoo Yamazaki; Takayuki Miyazawa; Yoshinori Tsukahara; Masahiro Kurozumi; Yugo Iwaya; Tadanobu Nagaya; Takeji Umemura
Gastro hep advances, 2(5), 652-655, 2023
Lead - Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience.
Taiki Okumura; Takuro Noguchi; Nodoka Sekiguchi; Takashi Kobayashi; Shintaro Kanda; Kouichi Ida; Tomonori Minagawa; Shigeo Tokumaru; Takeji Umemura; Tomonobu Koizumi
Chemotherapy, 68(2), 87-94, 2023
Lead - 【自己免疫性肝疾患-いま何が問題となっているのか?】原発性胆汁性胆管炎の予後予測
山下裕騎, 梅村武司
医学のあゆみ, 283(11 12), 1057-1059, Dec. 2022
Lead - Comparative analysis of humoral responses to BNT162b2 vaccine among patients with hematologic disorders and organ transplant recipients.
Nakazawa, Hideyuki; Sakai, Kaoko; Sudo, Yuriko; Iwabuchi, Ryohei; Sakai, Hitoshi; Nishina, Sayaka; Kawakami, Toru; Kawakami, Fumihiro; Matsuzawa, Shuji; Ito, Toshiro; Kitahara, Mari; Kamijo, Yuji; Umemura, Takeji; Ushiki, Atsuhito; Kanai, Shinichiro; Tsuchiya, Hiroyuki; Ishida, Fumihiro
TRANSPLANT IMMUNOLOGY, 75, 101713-101713, Dec. 2022
Lead - Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients
Iwadare T, Kimura T, Tanaka N, Yamazaki T, Wakabayashi SI, Okumura T, Kobayashi H, Yamashita Y, Pydi SP, Nakajima T, Iwaya M, Sugiura A, Joshita S, Uehara T, Umemura T:
Sci Rep, 12(1), 18900-18900, Nov. 2022
Lead - Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD
Iwadare T, Kimura T, Kunimoto H, Tanaka N, Wakabayashi SI, Yamazaki T, Okumura T, Kobayashi H, Yamashita Y, Sugiura A, Joshita S, Umemura T
Biomedicines, 10(11), Nov. 2022
Lead - Serum Leucine-Rich alpha2 Glycoprotein: A Biomarker for Predicting the Presence of Ulcerative Colitis but Not Ulcerative Proctitis
Horiuchi I, Horiuchi A, Umemura T
J Clin Med, 11(21), Nov. 2022
Lead - 肝疾患病態解明のための細胞生物学的アプローチ 脂肪細胞における内在性Gq受容体経路の活性化は糖脂質代謝を改善させる
木村 岳史; 田中 直樹; 梅村 武司
肝臓, 63(Suppl.3), A686-A686, Oct. 2022
Lead - 自己免疫性肝疾患の新規エビデンス 脂質異常症合併原発性胆汁性胆管炎患者におけるペマフィブラート治療と中期的な生化学的変動に関する検討
城下 智; 木村 岳史; 梅村 武司
肝臓, 63(Suppl.3), A706-A706, Oct. 2022
Lead - 【IgG4関連疾患大全-自己免疫性膵炎とIgG4関連硬化性胆管炎を中心に-】その他のIgG4関連疾患の病態,診断と治療 IgG4関連肝疾患
梅村武司
胆と膵, 43(臨増特大), 1283-1286, Oct. 2022
Lead - Quantitative changes of lipoprotein(a) in chronic hepatitis C patients achieving a sustained virological response by direct-acting antivirals
Okumura, Taiki; Joshita, Satoru; Sugiura, Ayumi; Ota, Masao; Umemura, Takeji
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 46(8), 102011-102011, Oct. 2022
Lead - No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy
Korenaga M, Murata K, Izumi N, Tamaki N, Yokosuka O, Takehara T, Sakamoto N, Suda G, Nishiguchi S, Enomoto H, Ikeda F, Yanase M, Toyoda H, Genda T, Umemura T, Yatsuhashi H, Yamasaki K, Ide T, Toda N, Kanda T, Nirei K, Ueno Y, Haga H, Nishigaki Y, Nakane K, Omata M, Mochizuki H, Aoki Y, Imamura M, Kanto T, Mizokami M
Glob Health Med, 4(4), 216-224, Sep. 2022
Lead - The levels of IL-1 beta and soluble IL-1 receptors in patients with IgG4-related periaortitis/periarteritis
Ashihara, Norihiro; Ota, Masao; Fujinaga, Yasunari; Ozawa, Makiko; Kuraishi, Yasuhiro; Watanabe, Takayuki; Hamano, Hideaki; Joshita, Satoru; Kawa, Shigeyuki; Umemura, Takeji
ADVANCES IN MEDICAL SCIENCES, 67(2), 257-261, Sep. 2022
Lead - 若手に役立つ議論・オピニオンリーダーからのメッセージ HBs抗原消失後の核酸アナログはいつまで続けるのか どういう場合に、やめても良いと考えるか
小林浩幸, 城下智, 梅村武司
肝臓クリニカルアップデート, 8(1), 63-68, Jul. 2022
Lead - 【ウイルス肝炎Annual Update】B型肝炎 HBコア関連抗原のエビデンス
奥村太規, 城下智, 梅村武司
肝胆膵, 85(1), 71-77, Jul. 2022
Lead - NAFLD/NASH診療-全身疾患としての位置づけ 脂肪細胞における受容体介在性Gqシグナル伝達は、全身のグルコース代謝恒常性と脂質恒常性の重要な調節因子である(Receptor-mediated Gq signaling in adipocytes as a critical modulator of systemic glucose and lipid homeostasis)
木村 岳史; 田中 直樹; 梅村 武司
肝臓, 63(Suppl.1), A54-A54, Apr. 2022
Lead - 2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease
Fujimori, Naoyuki; Kimura, Takefumi; Tanaka, Naoki; Yamazaki, Tomoo; Okumura, Taiki; Kobayashi, Hiroyuki; Wakabayashi, Shun-Ichi; Yamashita, Yuki; Sugiura, Ayumi; Pham, Jonathan; Pydi, Sai P.; Sano, Kenji; Joshita, Satoru; Umemura, Takeji
HEPATOLOGY RESEARCH, 52(4), 352-363, Apr. 2022
Lead - Gastric adenocarcinoma arising from hamartomatous inverted polyp during 8-year follow-up
Okamura T, Iwaya Y, Nagaya T, Muranaka F, Ota H, Umemura T
DEN Open, 2(1), e16, Mar. 2022
Lead - LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer
Kamakura, Masato; Uehara, Takeshi; Iwaya, Mai; Asaka, Shiho; Kobayashi, Shota; Nakajima, Tomoyuki; Kinugawa, Yasuhiro; Nagaya, Tadanobu; Yoshizawa, Takahiro; Shimizu, Akira; Ota, Hiroyoshi; Umemura, Takeji
DIAGNOSTIC PATHOLOGY, 17(1), 21-21, 2022
Lead - IL1R1 gene variants associate with disease susceptibility to IgG4-related periaortitis/periarteritis in IgG4-related disease
Umemura, Takeji; Fujinaga, Yasunari; Ashihara, Norihiro; Ozawa, Makiko; Kuraishi, Yasuhiro; Watanabe, Takayuki; Hamano, Hideaki; Meguro, Akira; Kawa, Shigeyuki; Ota, Masao
GENE, 820, 146212, 2022
Lead
- CD8(+) Lymphocyte Infiltration Is a Specific Feature of Colitis Induced by Immune Checkpoint Inhibitors
Takahashi, Yoshiyuki; Nagaya, Tadanobu; Iwaya, Yugo; Okamura, Takuma; Hirayama, Atsuhiro; Iwaya, Mai; Uehara, Takeshi; Umemura, Takeji
DIGESTIVE DISEASES AND SCIENCES, 68(2), 451-459, 2022
Lead - Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan
Sakamoto, Kazumasa; Ito, Kiyoaki; Yotsuyanagi, Hiroshi; Yatsuhashi, Hiroshi; Tanaka, Yasuhito; Hige, Shuhei; Takikawa, Yasuhiro; Ueno, Yoshiyuki; Yamamoto, Kazuhide; Imazeki, Fumio; Inoue, Jun; Kurosaki, Masayuki; Umemura, Takeji; Toyoda, Hidenori; Mita, Eiji; Michitaka, Kojiro; Maeshiro, Tatsuji; Yamada, Norie; Suetsugu, Atsushi; Kawanaka, Miwa; Seko, Yuya; Matsuura, Kentaro; Okumura, Akinori; Fukuzawa, Yoshitaka; Sugiyama, Masaya; Mizokami, Masashi; Yoneda, Masashi
JOURNAL OF GASTROENTEROLOGY, 57(12), 971-980, 2022
Lead - Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development
Hara, Daichi; Okamura, Takuma; Iwaya, Yugo; Nagaya, Tadanobu; Ota, Hiroyoshi; Umemura, Takeji
HELICOBACTER, 27(6), e12934, 2022
Lead - ESD後に出血を繰り返した後天性血友病Aの1例
岩垂隆諒, 長屋匡信, 岩谷勇吾, 菅智明, 梅村武司
Gastroenterological Endoscopy, 63(12), 2474-2480, Dec. 2021
Lead - I shall be released (from infinite HBV nucleos(t)ide analog therapy): Japanese experience
Enomoto M, Umemura T, Suzuki F
J Hepatol, 75(6), 1496-1497, Dec. 2021
Lead - Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease
Kimura T, Singh S, Tanaka N, Umemura T
Front Endocrinol, 12, 773432, Dec. 2021
Lead - Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myeloma: Case report and review of the literature
Yamazaki T, Joshita S, Ichijo T, Kobayashi H, Wakabayashi SI, Yamashita Y, Sugiura A, Kawakami F, Nakazawa H, Umemura T:
J Infect Chemother, 27(12), 1750-1755-1755, Dec. 2021
Lead - Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients
Joshita S, Ota M, Kobayashi H, Wakabayashi SI, Yamashita Y, Sugiura A, Yamazaki T, Tanaka E, Umemura T
Sci Rep, 11(1), 21424, Nov. 2021
Lead - IMPACT OF KIR/HLA PAIRS ON HEPATOCELLULAR CARCINOMA IN HEPATITIS C VIRUS CIRRHOTIC PATIENTS
Umemura, Takeji; Joshita, Satoru; Saito, Hiromi; Ota, Masao
HEPATOLOGY, 74, 648A-648A, Oct. 2021
Lead - aMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C
Yamashita Y, Joshita S, Sugiura A, Yamazaki T, Kobayashi H, Wakabayashi SI, Yamada Y, Shibata S, Kunimoto H, Iwadare T, Matsumura M, Miyabayashi C, Okumura T, Ozawa S, Nozawa Y, Kobayashi N, Komatsu M, Fujimori N, Saito H, Umemura T
Hepatol Res, 51(9), 933-942-942, Sep. 2021
Lead - A Case of Multiple Perineuriomas in the Colon With Underlying Neurofibromatosis Type I
Tsuchiya T, Iwaya Y, Iwaya M, Okamura T, Nagaya T, Umemura T
ACG Case Reports Journal, 8(9), e00665, Sep. 2021
Lead - Impact of DNA double-strand breaks on pancreaticobiliary maljunction carcinogenesis
Kuraishi Y, Uehara T, Muraki T, Iwaya M, Kinugawa Y, Nakajima T, Watanabe T, Miyagawa Y, Umemura T:
Diagn Pathol, 16(1), 72-72, Sep. 2021
Lead - A Case of Liver Metastasis in Primary Renal Cell Carcinoma Diagnosed by Hepatectomy after 9 Years of Follow-up of Cystic Liver Lesion
SHIMIZU Yuki, SUGIURA Ayumi, JOSHITA Satoru, KOBAYASHI Hiroyuki, WAKABAYASHI Shun-ichi, YAMASHITA Yuki, YAMAZAKI Tomoo, UEHARA Takeshi, SHIMIZU Akira, SOEJIMA Yuji,UMEMURA Takeji
Shinshu Medical Journal, 69(4), 209-215, Aug. 2021
Lead - Clinicopathological features of nodular gastritis in three classes of age
Kako S, Iwaya Y, Nagaya T, Hara D, Okamura T, Iwaya M, Kurasawa S, Kato S, Nakayama Y, Akamatsu T, Umemura T
Helicobacter, 26(6), e12845, Aug. 2021
Lead - Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project
Kobayashi H, Joshita S, Akahane Y, Matsuzaki K, Yamada H, Aomura D, Joshita N, Midorikawa H, Suyama K, Ota M, Wakabayashi SI, Yamashita Y, Sugiura A, Yamazaki T, Misawa H, Umemura T
PLoS One, 16(8), e0256711-e0256711, Aug. 2021
Lead - 経皮内視鏡的胃瘻造設術後に胃壁内気腫を伴った胃蜂窩織炎を発症した1例
小山みずき, 倉石康弘, 加古里子, 芦原典宏, 渡邉貴之, 岩谷勇吾, 長屋匡信, 赤松泰次, 梅村武司
ENDOSCOPIC FORUM for digestive disease, 37(1), 5-11-11, Jul. 2021
Lead - Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct-acting antivirals
Joshita S, Yamashita Y, Okamoto T, Usami Y, Sugiura A, Yamazaki T, Kakino A, Ota M, Sawamura T, Umemura T
Hepatol Res, 51(7), 758-766, Jul. 2021
Lead - Adult Case of Acute Hepatitis Associated with Primary Cytomegalovirus Infection in Remission Phase of Crohn's Disease
YAMAZAKI Tomoo, JOSHITA Satoru, OHNO Kazuyuki, SUGA Tomoaki, KOBAYASHI Hiroyuki, WAKABAYASHI Shun-ichi, YAMASHITA Yuki, SUGIURA Ayumi, UMEMURA Takeji
Shinshu Medical Journal, 69(3), 127-133, Jun. 2021
Lead - An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection
Koyama M, Yamazaki T, Joshita S, Ito A, Ono K, Watanabe T, Yamashita Y, Sugiura A, Kobayashi M, Sato Y, Takahashi M, Okamoto H, Umemura T
Intern Med, 60(12), 1863-1870, Jun. 2021
Lead - Intestinal Obstruction Due to Mesenteric Inflammatory Veno-occlusive Disease: A Case Report and Summary of the Literature
Kobayashi H, Joshita S, Nozawa Y, Tanaka T, Hashigami K, Suganuma T, Takahashi T, Nakamura Y, Ogiwara H, Sano K, Umemura T
Shinshu Medical Journal, 69(3), 141-147, Jun. 2021
Lead - Investigation of the Effect of KIR-HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients
Umemura T, Joshita S, Saito H, Wakabayashi SI, Kobayashi H, Yamashita Y, Sugiura A, Yamazaki T, Ota M:
Cancers (Basel), 13(13), 3267-3267, Jun. 2021
Lead - Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection: Case Report and Summary of the Literature
Yamashita Y, Joshita S, Kobayashi H, Wakabayashi SI, Sugiura A, Yamazaki T, Umemura T
Medicina (Kaunas), 57(3), 280, May 2021
Lead - Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease
Wakabayashi SI, Joshita S, Kimura K, Motoki H, Kobayashi H, Yamashita Y, Sugiura A, Yamazaki T, Kuwahara K, Umemura T
PLoS One, 16(4), e0249435, Apr. 2021
Lead - Successful treatment of gallstone ileus with double-balloon enteroscopy-assisted electrohydraulic lithotripsy
Kako S, Iwaya Y, Nagaya T, Umemura T
Dig Liver Dis, 53(4), 498-499, Apr. 2021
Lead - 【肝臓学2020:最新の9の話題】肝発癌抑制を目指したB型肝炎治療
梅村武司, 城下智
消化器・肝臓内科, 9(3), 283-288, Mar. 2021
Lead - Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD
Kimura T, Tanaka N, Fujimori N, Yamazaki T, Katsuyama T, Iwashita Y, Pham J, Joshita S, Pydi SP, Umemura T
Liver Int, 41(3), 505-514, Mar. 2021
Lead - 【肝・胆道系症候群(第3版)-その他の肝・胆道系疾患を含めて-肝臓編(上)】自己免疫性肝疾患 IgG4関連硬化性胆管炎
梅村武司, 渡邉貴之
日本臨床, 別冊, 169-173, Jan. 2021
Lead - Relationship of early acute complications and insertion site in push method percutaneous endoscopic gastrostomy
Suzuki H, Joshita S, Nagaya T, Sato K, Ito A, Suga T, Umemura T
Sci Rep, 10(1), 20551-20551, Nov. 2020
Lead - Editorial: FAST score- a new predictive marker for HCC after SVR
Joshita S, Umemura T
Aliment Pharmacol Ther, 52(7), 1222-1223, Oct. 2020
Last - Invasive liver abscess syndrome accompanied by spondylodiscitis: a case report and review of the literature
Wakabayashi SI, Kimura T, Tanaka N, Pham J, Tanaka T, Higuchi S, Kobayashi J, Umemura T, Iijima A
Clin J Gastroenterol, 13(5), 927-934-934, Oct. 2020
Lead - A case report of pancreatic panniculitis due to acute pancreatitis with intraductal papillary mucinous neoplasm
Yamashita Y, Joshita S, Ito T, Maruyama M, Wada S, Umemura T
BMC Gastroenterol, 20(1), 286, Aug. 2020
Last - 減量導入したレゴラフェニブが奏功し、12ヵ月以上の長期投与が可能であった多発肝細胞癌・胸椎および副腎転移の1例
岩垂隆諒, 山崎智生, 城下智, 藤森尚之, 金井圭太, 山下裕騎, 高橋芳之, 杉浦亜弓, 梅村武司
ACTA HEPATOLOGICA JAPONICA, 61(8), 426-433-433, Aug. 2020
Last - Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection
Joshita S, Sugiura A, Umemura T, Yamazaki T, Fujimori N, Matsumoto A, Usami Y, Tanaka E:
JGH Open, 4(4), 574-581-581, Aug. 2020
Lead - Polymorphism at rs9264942 is associated with HLA-C expression and inflammatory bowel disease in the Japanese
Suzuki H, Joshita S, Hirayama A, Shinji A, Mukawa K, Sako M, Yoshimura N, Suga T, Umemura T, Ashihara N, Yamazaki T, Ota M
Sci Rep, 10(1), 12424, Jul. 2020
Lead - 【IgG4関連疾患-診断と治療の最新動向】IgG4関連消化器疾患の診断と治療
渡邉貴之, 梅村武司, 川茂幸
カレントテラピー, 38(7), 669-675, Jul. 2020
Lead - Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis
Joshita S, Yamashita Y, Sugiura A, Uehara T, Usami Y, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E, Umemura T
J Gastroenterol Hepatol, 35(7), 1208-1214, Jul. 2020
Last - Correlation of Pancreatic T1 Values Using Modified Look-Locker Inversion Recovery Sequence (MOLLI) with Pancreatic Exocrine and Endocrine Function
Ashihara N, Watanabe T, Kako S, Kuraishi Y, Ozawa M, Shigefuji S, Kanai K, Usami Y, Yamada A, Umemura T, Fujinaga Y
J Clin Med, 9(6), 1805, Jun. 2020
Lead - B型肝炎再活性化発症に関連するウイルス側因子
伊藤 清顕; 梅村 武司; 坂本 和賢; 奥村 彰規; 田中 榮司; 米田 政志
ACTA HEPATOLOGICA JAPONICA, 61(5), 237-239-239, May 2020
Lead - Congestive hepatopathy and acute pancreatitis as severe complications of mixed connective tissue disease
Kurihara S, Kimura T, Tanaka N, Yanagisawa T, Kobayashi H, Kanai K, Umemura T, Kobayashi M, Mori H, Wada S
Clin J Gastroenterol, 13(3), 434-442-442, Apr. 2020
Lead - 【消化器領域におけるIgG4関連疾患】IgG4関連自己免疫性肝炎
梅村武司
消化器内科, 2(4), 83-91-91, Apr. 2020
Lead - Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases
Sugiura, Ayumi; Joshita, Satoru; Yamashita, Yuki; Yamazaki, Tomoo; Fujimori, Naoyuki; Kimura, Takefumi; Matsumoto, Akihiro; Wada, Shuichi; Mori, Hiromitsu; Shibata, Soichiro; Yoshizawa, Kaname; Morita, Susumu; Furuta, Kiyoshi; Kamijo, Atsushi; Iijima, Akihiro; Kako, Satoko; Maruyama, Atsushi; Kobayashi, Masakazu; Komatsu, Michiharu; Matsumura, Makiko; Miyabayashi, Chiharu; Ichijo, Tetsuya; Takeuchi, Aki; Koike, Yuriko; Gibo, Yukio; Tsukadaira, Toshihisa; Inada, Hiroyuki; Nakano, Yoshiyuki; Usuda, Seiichi; Kiyosawa, Kendo; Tanaka, Eiji; Umemura, Takeji
BIOMEDICINES, 8(4), --74, Apr. 2020
Lead - 長野県におけるC型慢性肝炎に対する直接作用型抗ウイルス剤治療の実臨床における成績と課題
杉浦 亜弓; 城下 智; 山下 裕騎; 山崎 智生; 藤森 尚之; 松本 晶博; 梅村 武司; 五十嵐 浩二; 宇佐美 陽子; 和田 秀一; 森 宏光; 柴田 壮一郎; 吉澤 要; 森田 進; 古田 清; 上條 敦; 飯嶌 章博; 加古 里子; 丸山 敦史; 小林 正和; 小松 通治; 松村 真生子; 宮林 千春; 一條 哲也; 竹内 安紀; 小池 ゆり子; 宜保 行雄; 塚平 俊久; 稲田 浩之; 中野 善之; 薄田 誠一; 清澤 研道; 田中 榮司
長野県医学会雑誌, 50, 31-33, Mar. 2020
Lead - 【ウイルス肝炎アップデート】B型・C型肝炎の治療と予防 B型肝炎ウイルスの再活性化
梅村武司
診断と治療, 108(2), 215-220-220, Feb. 2020
Lead - Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus
Fujimori N, Tanaka N, Kimura T, Sano K, Horiuchi A, Kato N, Takahashi Y, Kuribayashi N, Sugiura A, Yamazaki T, Joshita S, Umemura T, Matsumoto A, Tanaka E
Clin J Gastroenterol, 13(1), 83-89, Feb. 2020
Lead - Clinical In uence of Hepatitis C Virus Eradication by Direct-acting Antivirals on Lipid Levels and “Ningen Dock” Health Check-up Categories in Patients with Chronic Hepatitis C Virus Infection
Joshita S, Sugiura A, Yamazaki T, Fujimori N, Yamashita Y, Matsumoto A, Eiji T, Takeji U
Ningen Dock International, 7, 19-25, 2020
Last - A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis
Yagi, Minami; Matsumoto, Kosuke; Komori, Atsumasa; Abe, Masanori; Hashimoto, Naoaki; Inao, Mie; Namisaki, Tadashi; Kawata, Kazuhito; Ninomiya, Masashi; Fujii, Hideki; Takahashi, Atsushi; Kang, Jong-Hon; Takamura, Masaaki; Arakawa, Mie; Joshita, Satoru; Sato, Ken; Itakura, Jun; Nomura, Takako; Kakisaka, Keisuke; Kaneko, Akira; Tamura, Yamato; Miura, Ryo; Aiso, Mitsuhiko; Arizumi, Toshihiko; Asaoka, Yoshinari; Kikuchi, Kentaro; Takikawa, Yasuhiro; Masaki, Tsutomu; Umemura, Takeji; Honda, Akira; Ohira, Hiromasa; Kawada, Norifumi; Yoshiji, Hitoshi; Mochida, Satoshi; Takikawa, Hajime; Tanaka, Atsushi; JPBCSG
LIVER INTERNATIONAL, 40(8), --1933, 2020
Lead - Virological Factors Associated With the Occurrence of Hepatitis B Virus (HBV) Reactivation in Patients With Resolved HBV Infection Analyzed Through Ultradeep Sequencing
Sakamoto, Kazumasa; Umemura, Takeji; Ito, Kiyoaki; Okumura, Akinori; Joshita, Satoru; Ota, Masao; Sugiyama, Masaya; Mizokami, Masashi; Yoneda, Masashi; Tanaka, Eiji;
JOURNAL OF INFECTIOUS DISEASES, 221(3), 400-407, 2020 - Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis
Honda, Akira; Tanaka, Atsushi; Kaneko, Tetsuji; Komori, Atsumasa; Abe, Masanori; Inao, Mie; Namisaki, Tadashi; Hashimoto, Naoaki; Kawata, Kazuhito; Takahashi, Atsushi; Ninomiya, Masashi; Kang, Jong-Hon; Arakawa, Mie; Yamagiwa, Satoshi; Joshita, Satoru; Umemura, Takeji; Sato, Ken; Kaneko, Akira; Kikuchi, Kentaro; Itakura, Jun; Nomura, Takako; Kakisaka, Keisuke; Fujii, Hideki; Kawada, Norifumi; Takikawa, Yasuhiro; Masaki, Tsutomu; Ohira, Hiromasa; Mochida, Satoshi; Yoshiji, Hitoshi; Iimuro, Satoshi; Matsuzaki, Yasushi; Takikawa, Hajime; Japan PBC Study Grp
HEPATOLOGY, 70(6), 2035-2046, Dec. 2019
Lead - KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
Umemura, Takeji; Joshita, Satoru; Saito, Hiromi; Yoshizawa, Kaname; Norman, Gary L.; Tanaka, Eiji; Ota, Masao
JHEP REPORTS, 1(5), 353-360, Nov. 2019
Lead - Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis
Joshita, Satoru; Umemura, Takeji; Yamashita, Yuki; Sugiura, Ayumi; Yamazaki, Tomoo; Fujimori, Naoyuki; Matsumoto, Akihiro; Tanaka, Eiji
HEPATOLOGY RESEARCH, 49(10), 1236-1243, Oct. 2019
Lead - CLINICAL SIGNIFICANCE OF TUMOR MARKERS IN SURVEILLANCE FOR HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS: A MULTICENTER PROSPECTIVE COHORT STUDY IN JAPAN
Uchino, Koji; Tateishi, Ryosuke; Fujiwara, Naoto; Mitsuhiko, Moriyama; Eguchi, Yuichiro; Toyoda, Hidenori; Ida, Yoshiyuki; Karino, Yoshiyasu; Kudo, Masatoshi; Chuma, Makoto; Takuma, Yoshitaka; Kaneko, Shuichi; Kato, Naoya; Chayama, Kazuaki; Izumi, Namiki; Itoi, Takao; Sakaida, Isao; Komeda, Hideyuki; Umemura, Takeji; Ishikawa, Toru; Nakamuta, Makoto; Takaki, Akinobu; Terai, Shuji; Ido, Akio; Enomoto, Nobuyuki; Yoshida, Hitoshi; Baba, Toshiyuki; Torimura, Takuji; Hiasa, Yoichi; Ogawa, Chikara; Takehara, Tetsuo; Kumada, Takashi; Koike, Kazuhiko
HEPATOLOGY, 70, 225A-226A, Oct. 2019
Lead - MULTI-CENTER AND PROSPECTIVE COHORT STUDY OF 599 JAPANESE PATIENTS WITH HCV GENOTYPE 1 INFECTION REVEALS SUSTAINED VIROLOGICAL RESPONSE BY LEDIPASVIR/SOFOSBUVIR REDUCES THE INCIDENCE OF HEPATOCELLULAR CARCINOMA AS SAME AS PEG-INTERFERON PLUS RIBAVIRIN
Korenaga, Masaaki; Izumi, Namiki; Tamaki, Nobuharu; Yokosuka, Osamu; Kanda, Tatsuo; Takehara, Tetsuo; Sakamoto, Naoya; Suda, Goki; Nishiguchi, Shuhei; Enomoto, Hirayuiki; Ikeda, Fusao; Yanase, Mikio; Toyoda, Hidenori; Genda, Takuya; Umemura, Takeji; Yatsuhashi, Hiroshi; Yamasaki, Kazumi; Ide, Tatsuya; Toda, Nobuo; Nirei, Kazushige; Ueno, Yoshiyuki; Haga, Hiroaki; Nishigaki, Yohichi; Nakane, Kunio; Omata, Masao; Mochiduki, Hitoshi; Kanto, Tatsuya; Mizokami, Masashi
HEPATOLOGY, 70, 368A-369A, Oct. 2019
Lead - KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTORS/HUMAN LEUKOCYTE ANTIGEN GENOTYPES CONFER SUSCEPTIBILITY AND PROGRESSION IN PATIENTS WITH AUTOIMMUNE HEPATITIS
Umemura, Takeji; Joshita, Satoru; Yamashita, Yuki; Yoshizawa, Kaname; Norman, Gary L.; Tanaka, Eiji; Ota, Masao
HEPATOLOGY, 70, 871A-871A, Oct. 2019
Lead - Virological Factors Associated with the Occurrence of HBV Reactivation in Patients with Resolved HBV Infection Analyzed through Ultradeep Sequencing.
Sakamoto K; Umemura T; Ito K; Okumura A; Joshita S; Ota M; Sugiyama M; Mizokami M; Yoneda M; Tanaka E
The Journal of infectious diseases, 221(3), 400-407, Sep. 2019, Refereed, Not invited
Lead - Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection
Kobayashi, Satoshi; Joshita, Satoru; Yamamoto, Chikara; Yanagisawa, Takumi; Miyazawa, Takayuki; Miyazawa, Megumi; Kubota, Daisuke; Sato, Junichi; Umemura, Takeji; Tanaka, Eiji
MEDICINE, 98(30), --e16619, Jul. 2019
Lead - Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study
Umemura, Takeji; Joshita, Satoru; Shibata, Soichiro; Sugiura, Ayumi; Yamazaki, Tomoo; Fujimori, Naoyuki; Matsumoto, Akihiro; Tanaka, Eiji
MEDICINE, 98(6), --e14475, Feb. 2019, Not invited
Lead - POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33
Hitomi, Yuki; Ueno, Kazuko; Kawai, Yosuke; Nishida, Nao; Kojima, Kaname; Kawashima, Minae; Aiba, Yoshihiro; Nakamura, Hitomi; Kouno, Hiroshi; Kouno, Hirotaka; Ohta, Hajime; Sugi, Kazuhiro; Nikami, Toshiki; Yamashita, Tsutomu; Katsushima, Shinji; Komeda, Toshiki; Ario, Keisuke; Naganuma, Atsushi; Shimada, Masaaki; Hirashima, Noboru; Yoshizawa, Kaname; Makita, Fujio; Furuta, Kiyoshi; Kikuchi, Masahiro; Naeshiro, Noriaki; Takahashi, Hironao; Mano, Yutaka; Yamashita, Haruhiro; Matsushita, Kouki; Tsunematsu, Seiji; Yabuuchi, Iwao; Nishimura, Hideo; Shimada, Yusuke; Yamauchi, Kazuhiko; Komatsu, Tatsuji; Sugimoto, Rie; Sakai, Hironori; Mita, Eiji; Koda, Masaharu; Nakamura, Yoko; Kamitsukasa, Hiroshi; Sato, Takeaki; Nakamuta, Makoto; Masaki, Naohiko; Takikawe, Hajime; Tanaka, Atsushi; Ohira, Hiromasa; Zeniya, Mikio; Abe, Masanori; Kaneko, Shuichi; Honda, Masao; Arai, Kuniaki; Arinaga-Hino, Teruko; Hashimoto, Etsuko; Taniai, Makiko; Umemura, Takeji; Joshita, Satoru; Nakao, Kazuhiko; Ichikawa, Tatsuki; Shibata, Hidetaka; Takaki, Akinobu; Yamagiwa, Satoshi; Seike, Masataka; Sakisaka, Shotaro; Takeyama, Yasuaki; Harada, Masaru; Senju, Michio; Yokosuka, Osamu; Kanda, Tatsuo; Ueno, Yoshiyuki; Ebinuma, Hirotoshi; Himoto, Takashi; Murata, Kazumoto; Shimoda, Shinji; Nagaoka, Shinya; Abiru, Seigo; Komori, Atsumasa; Migita, Kiyoshi; Ito, Masahiro; Yatsuhashi, Hiroshi; Maehara, Yoshihiko; Uemoto, Shinji; Kokudo, Norihiro; Nagasaki, Masao; Tokunaga, Katsushi; Nakamura, Minoru
SCIENTIFIC REPORTS, 9(1), -, 2019, Not invited
Lead - Direct Acting Antiviral（DAA）の登場で変化を遂げたＣ型肝炎治療
杉浦 亜弓; 城下 智; 梅村 武司
Shinshu Medical Journal, 66(6), 475-477-477, Dec. 2018
Last - Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
Satoru Joshita; Takeji Umemura; Yoko Usami; Yuki Yamashita; Gary L. Norman; Ayumi Sugiura; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Koji Igarashi; Kaname Yoshizawa; Masao Ota; Eiji Tanaka
Scientific Reports, 8(1), -, Dec. 2018, Not invited
Lead - Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
Satoru Joshita; Takeji Umemura; Yoko Usami; Yuki Yamashita; Gary L. Norman; Ayumi Sugiura; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Koji Igarashi; Kaname Yoshizawa; Masao Ota; Eiji Tanaka
Scientific Reports, 8(1), -, Dec. 2018, Not invited
Lead - Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients
Komatsu, Michiharu; Tanaka, Naoki; Kimura, Takefumi; Fujimori, Naoyuki; Sano, Kenji; Horiuchi, Akira; Sugiura, Ayumi; Yamazaki, Tomoo; Shibata, Soichiro; Joshita, Satoru; Umemura, Takeji; Matsumoto, Akihiro; Tanaka, Eiji
HEPATOLOGY RESEARCH, 48(13), 1092-1098, Dec. 2018, Not invited
Lead - Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals
Sugiura, Ayumi; Joshita, Satoru; Umemura, Takeji; Yamazaki, Tomoo; Fujimori, Naoyuki; Kimura, Takefumi; Matsumoto, Akihiro; Igarashi, Koji; Usami, Yoko; Wada, Shuichi; Mori, Hiromitsu; Shibata, Soichiro; Yoshizawa, Kaname; Morita, Susumu; Furuta, Kiyoshi; Kamijo, Atsushi; Iijima, Akihiro; Kako, Satoko; Maruyama, Atsushi; Kobayashi, Masakazu; Komatsu, Michiharu; Matsumura, Makiko; Miyabayashi, Chiharu; Ichijo, Tetsuya; Takeuchi, Aki; Koike, Yuriko; Gibo, Yukio; Tsukadaira, Toshihisa; Inada, Hiroyuki; Kiyosawa, Kendo; Tanaka, Eiji
JOURNAL OF VIRAL HEPATITIS, 25(12), 1462-1471, Dec. 2018, Not invited
Lead - Autotaxin is a non-invasive biomarker for estimating chronic liver disease status
Joshita, Satoru; Umemura, Takeji; Usami, Yoko; Sugiura, Ayumi; Yamazaki, Tomoo; Fujimori, Naoyuki; Matsumoto, Akihiro; Igarashi, Koji; Ota, Masao; Tanaka, Eiji
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 33, 216-216, Nov. 2018
Lead - Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C
Umemura, Takeji; Yamazaki, Tomoo; Joshita, Satoru; Sugiura, Ayumi; Fujimori, Naoyuki; Matsumoto, Akihiro; Ota, Masao; Tanaka, Eiji
CYTOKINE, 111, 357-363, Nov. 2018, Not invited
Lead - The Risk of Hepatocellular Carcinoma Development after Sustained Virologic Response Are Similar between Japanese Patients with HCV Genotype 1 Infection Treated with Ledipasvir/Sofosbuvir and Protease Inhibitor with Peg-Interferon Plus Ribavirin.
Korenaga, Masaaki; Izumi, Namiki; Tamaki, Nobuharu; Yokosuka, Osamu; Takehara, Tetsuo; Sakamoto, Naoya; Suda, Goki; Nishiguchi, Shuhei; Enomoto, Hirayuki; Ikeda, Fusao; Yanase, Mikio; Toyoda, Hidenori; Genda, Takuya; Umemura, Takeji; Yatsuhashi, Hiroshi; Yamasaki, Kazumi; Ide, Tatsuya; Toda, Nobuo; Kanda, Tatsuo; Nirei, Kazushige; Ueno, Yoshiyuki; Haga, Hiroaki; Nishigaki, Yohichi; Omata, Masao; Mochiduki, Hitoshi; Kanto, Tatsuya; Mizokami, Masashi
HEPATOLOGY, 68, 535A-536A, Oct. 2018
Lead - The Risk of Hepatocellular Carcinoma Development after Sustained Virologic Response Are Similar between Japanese Patients with HCV Genotype 1 Infection Treated with Ledipasvir/Sofosbuvir and Protease Inhibitor with Peg-Interferon Plus Ribavirin.
Korenaga Masaaki; Izumi Namiki; Tamaki Nobuharu; Yokosuka Osamu; Takehara Tetsuo; Sakamoto Naoya; Suda Goki; Nishiguchi Shuhei; Enomoto Hirayuki; Ikeda Fusao; Yanase Mikio; Toyoda Hidenori; Genda Takuya; Umemura Takeji; Yatsuhashi Hiroshi; Yamasaki Kazumi; Ide Tatsuya; Toda Nobuo; Kanda Tatsuo; Nirei Kazushige; Ueno Yoshiyuki; Haga Hiroaki; Nishigaki Yohichi; Omata Masao; Mochiduki Hitoshi; Kanto Tatsuya; Mizokami Masashi
HEPATOLOGY, 68, 535A-536A, Oct. 2018, Not invited
Lead - Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma
Wakabayashi SI; Kimura T; Tanaka N; Joshita S; Kawata K; Umemura T; Hiroshima Y; Mori H; Kobayashi H; Wada S; Tanaka E
Clin J Gastroenterol, 11(4), 302-308, Aug. 2018, Not invited
Lead - Hepatic Angiosarcoma with Kasabach-Merritt Phenomenon: A Case Report and Review of the Literature
Fujii F; Kimura T; Tanaka N; Kubota D; Sugiura A; Umemura T; Wada S; Tanaka E
Ann Hepatol, 17(4), 655-660-660, Jul. 2018, Not invited
Lead - A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature
Tomoo Yamazaki; Satoru Joshita; Eriko Kasuga; Kazuki Horiuchi; Ayumi Sugiura; Naoyuki Fujimori; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Journal of Infection and Chemotherapy, 24(5), 393-397, May 2018, Not invited
Lead - Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey
Joshita, Satoru; Yoshizawa, Kaname; Umemura, Takeji; Ohira, Hiromasa; Takahashi, Atsushi; Harada, Kenichi; Kan, Jong-Hon; Koike, Kazuhiko; Zeniya, Mikio; Takaki, Akinobu; Torimura, Takuji; Abe, Masanori; Tanaka, Atsushi; Takikawa, Hajime;
GASTROENTEROLOGY, 154(6), S1215-S1215, May 2018 - Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fbrosis
Takefumi Kimura; Naoki Tanaka; Naoyuki Fujimori; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
World Journal of Gastroenterology, 24(13), 1440-1450, Apr. 2018, Not invited
Lead - 肝硬変の成因別実態 長野県における肝硬変の成因実態
杉浦 亜弓; 城下 智; 山崎 智生; 藤森 尚之; 木村 岳史; 小松 通治; 梅村 武司; 松本 晶博; 田中 榮司
肝臓, 59(Suppl.1), A288-A288, Apr. 2018
Lead - KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients
Saito H; Umemura T; Joshita S; Yamazaki T; Fujimori N; Kimura T; Komatsu M; Matsumoto A; Tanaka E; Ota M
Oncotarget, 9(28), 19650-19661, Apr. 2018, Not invited
Lead - Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
Tomoo Yamazaki; Satoru Joshita; Takeji Umemura; Yoko Usami; Ayumi Sugiura; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Koji Igarashi; Masao Ota; Eiji Tanaka
PLoS ONE, 13(4), -, Apr. 2018, Not invited
Lead - Association between KIR-HLA combination and ulcerative colitis and Crohn’s disease in a Japanese population
Hiromi Saito; Atsuhiro Hirayama; Takeji Umemura; Satoru Joshita; Kenji Mukawa; Tomoaki Suga; Eiji Tanaka; Masao Ota
PLoS ONE, 13(4), -, Apr. 2018, Not invited
Lead - Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
Naoyuki Fujimori; Takeji Umemura; Takefumi Kimura; Naoki Tanaka; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Michiharu Komatsu; Yoko Usami; Kenji Sano; Koji Igarashi; Akihiro Matsumoto; Eiji Tanaka
World Journal of Gastroenterology, 24(11), 1239-1249, Mar. 2018, Not invited
Lead - Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection
Satoru Joshita; Yuki Ichikawa; Takeji Umemura; Yoko Usami; Ayumi Sugiura; Soichiro Shibata; Tomoo Yamazaki; Naoyuki Fujimori; Michiharu Komatsu; Akihiro Matsumoto; Koji Igarashi; Masao Ota; Eiji Tanaka
Hepatology Research, 48(4), 275-285, Mar. 2018, Not invited
Lead - Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey
Satoru Joshita; Kaname Yoshizawa; Takeji Umemura; Hiromasa Ohira; Atsushi Takahashi; Kenichi Harada; Nguyen Canh Hiep; Koichi Tsuneyama; Masayoshi Kage; Masayuki Nakano; Jong-Hon Kang; Kazuhiko Koike; Mikio Zeniya; Tetsuya Yasunaka; Akinobu Takaki; Takuji Torimura; Masanori Abe; Osamu Yokosuka; Atsushi Tanaka; Hajime Takikawa; The Japan Autoimmune Hepatitis Study Group (JAIHSG)
Journal of Gastroenterology, 53(9), 1-10, Feb. 2018, Not invited
Lead - Genetics and epigenetics in the pathogenesis of primary biliary cholangitis
Joshita S; Umemura T; Tanaka E; Ota M
Clin J Gastroenterol, 11(1), 11-18, Feb. 2018, Not invited
Lead - B型肝炎再活性化の対策 (特集 肝炎ウイルス克服時代の肝臓病学)
梅村 武司
日本内科学会雑誌, 107(1), 26-31-31, Jan. 2018, Not invited
Lead - A case of hepatocellular carcinoma with iliac metastasis achieving complete long-term remission by multidisciplinary therapy with radiation therapy, transcatheter arterial chemoembolization, and sorafenib
Shunichi Wakabayashi; Tomoo Yamazaki; Satoru Joshita; Masahiro Kurozumi; Ayumi Sugiura; Naoyuki Fujimori; Soichiro Shibata; Yuki Ichikawa; Susumu Morita; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Acta Hepatologica Japonica, 59(2), 117-124, 2018, Refereed, Not invited
Lead - Salmonella Enteritidis cholecystitis with chronic granulomatous disease
Yamashita Y; Kimura T; Tanaka N; Yazaki M; Itagaki T; Joshita S; Umemura T; Matsumoto A; Mori H; Wada S; Tanaka E
IDCases, 12, 49-52, 2018, Not invited
Lead - A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis
Yamazaki, Tomoo; Umemura, Takeji; Joshita, Satoru; Yoshizawa, Kaname; Tanaka, Eiji; Ota, Masao
SCIENTIFIC REPORTS, 8(1), -, 2018, Not invited
Lead - 多発肝細胞癌・腸骨転移に対し放射線照射・肝動脈化学塞栓術・sorafenib内服を組み合わせた集学的治療を行い長期寛解が得られた1例
若林 俊一; 山崎 智生; 城下 智; 黒住 昌弘; 杉浦 亜弓; 藤森 尚之; 柴田 壮一郎; 市川 雪; 森田 進; 小松 通治; 梅村 武司; 松本 晶博; 田中 榮司
ACTA HEPATOLOGICA JAPONICA, 59(2), 117-124-124, 2018, Not invited
Lead - ビタミンB6が著効したALAS2 R452H変異陽性X連鎖性鉄芽球性貧血
川上 徹; 中澤 英之; 川上 史裕; 松澤 周治; 須藤 裕里子; 酒井 均; 仁科 さやか; 妹尾 紀子; 妹尾 寧; 小松 通治; 梅村 武司; 山口 智美; 古庄 知己; 藤原 亨; 張替 秀郎; 石田 文宏
Shinshu Medical Journal, 59(4), 401-406-406, 2018, Not invited
Lead - Two Cases of Primary Biliary Cholangitis with Hepatocellular Carcinoma in a Non-cirrhotic Stage
SUGIURA Ayumi, JOSHITA Satoru, YAMASHITA Yuki, KIMURA Takefumi, YAMAZAKI Tomoo, FUJIMORI Naoyuki, KOMATSU Michiharu, MATSUMOTO Akihiro, KOBAYASHI Shota, UMEMURA Takeji, TANAKA Eiji
The Shinshu Medical Journal, 66(1), 39-49-49, 2018, Not invited
Lead - III．B型肝炎再活性化の対策
梅村 武司
日本内科学会雑誌, 107(1), 26-31, 2018
Lead - Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients
Takeji Umemura; Satoru Joshita; Hideaki Hamano; Kaname Yoshizawa; Shigeyuki Kawa; Eiji Tanaka; Masao Ota
JOURNAL OF HUMAN GENETICS, 62(11), 963-967, Nov. 2017, Not invited
Lead - Combination of Killer Immunoglobulin-like Receptor and HLA Genes is Associated with Hepatitis C Virus-Related Hepatocellular Carcinoma
Umemura, Takeji; Saito, Hiromi; Joshita, Satoru; Yamazaki, Tomoo; Tanaka, Eiji; Ota, Masao
HEPATOLOGY, 66, 124A-124A, Oct. 2017
Lead - Hepatocellular carcinoma development in Japanese patients with HCV genotype 1 infection who achieved sustained virologic response by ledipasvir/sofosbuvir and protease inhibitor with peginterferon plus ribavirin
Korenaga, Masaaki; Izumi, Namiki; Yokosuka, Osamu; Takehara, Tetsuo; Sakamoto, Naoya; Nishiguchi, Shuhei; Ikeda, Fusao; Yanase, Mikio; Toyoda, Hidenori; Genda, Takuya; Umemura, Takeji; Yatsuhashi, Hiroshi; Ide, Tatsuya; Toda, Nobuo; Nirei, Kazushige; Ueno, Yoshiyuki; Nishigaki, Yoichi; Nakane, Kunio; Kanto, Tatsuya; Omata, Masao; Mizokami, Masashi
HEPATOLOGY, 66, 563A-564A, Oct. 2017
Lead - Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury
Fujimori N; Komatsu M; Tanaka N; Iwaya M; Nakano H; Sugiura A; Yamazaki T; Shibata S; Iwaya Y; Muraki T; Ichikawa Y; Kimura T; Joshita S; Umemura T; Matsumoto A; Tanaka E
Clin J Gastroenterol, 10(5), 452-458, Oct. 2017, Not invited
Lead - Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis
Honda, Akira; Tanaka, Atsushi; Komori, Atsumasa; Abe, Masanori; Inao, Mie; Mochida, Satoshi; Namisaki, Tadashi; Yoshiji, Hitoshi; Hashimoto, Naoaki; Kawata, Kazuhito; Takahashi, Atsushi; Ohira, Hiromasa; Kang, Jong-Hon; Yamagiwa, Satoshi; Joshita, Satoru; Umemura, Takeji; Sato, Ken; Itakura, Jun; Kaneko, Akira; Kakisaka, Keisuke; Takikawa, Yasuhiro; Kikuchi, Kentaro; Takikawa, Hajime; Matsuzaki, Yasushi;
Hepatology, 66, 42A-43A, Oct. 2017 - 肝脂肪沈着量のsurrogate markerは存在するか
藤森 尚之; 小松 通治; 田中 直樹; 杉浦 亜弓; 山崎 智生; 柴田 壮一郎; 市川 雪; 木村 岳史; 城下 智; 梅村 武司; 松本 晶博; 田中 榮司
日本消化器病学会雑誌, 114(臨増大会), A769-A769, Sep. 2017
Lead - Association of serum autotaxin level with disease stage in Japanese patients with primary biliary cholangitis
Joshita, Satoru; Umemura, Takeji; Usami, Yoko; Sugiura, Ayumi; Yamazaki, Tomoo; Fujimori, Naoyuki; Komatsu, Michiharu; Matsumoto, Akihiro; Igarashi, Koji; Ota, Masao; Tanaka, Eiji
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32, 179-179, Sep. 2017
Lead - Two cases of non-cirrhotic primary biliary cirrhosis with complicating hepatocellular carcinoma
Sugiura, Ayumi; Joshita, Satoru; Yamashita, Yuki; Hihara, Yu; Fujimori, Naoyuki; Yamazaki, Tomoo; Maruyama, Yasuhiro; Shibata, Souichiro; Ichikawa, Yuki; Kimura, Takefumi; Ito, Tetsuya; Komatsu, Michiharu; Umemura, Takeji; Matsumoto, Akihiro; Tanaka, Eiji
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32, 186-186, Sep. 2017
Lead - 【ウイルス肝炎のすべて】血液伝播するウイルス肝炎 B型肝炎 B型肝炎に対する核酸アナログ/インターフェロン併用療法
梅村武司; 田中榮司
医学のあゆみ, 262(14), 1336-1340, Sep. 2017, Not invited
Lead - Association between lower air pressure and the onset of ischemic colitis: a case-control study
Takefumi Kimura; Akihiro Shinji; Naoki Tanaka; Masayoshi Koinuma; Maki Yamaura; Tadanobu Nagaya; Satoru Joshita; Michiharu Komatsu; Takeji Umemura; Akira Horiuchi; Shuichi Wada; Eiji Tanaka
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 29(9), 1071-1078, Sep. 2017, Not invited
Lead - Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
Takeji Umemura; Tomohiro Sekiguchi; Satoru Joshita; Tomoo Yamazaki; Soichiro Shibata; Yuki Ichikawa; Michiharu Komatsu; Akihiro Matsumoto; Zakera Shums; Gary L. Norman; Eiji Tanaka; Masao Ota
LIVER INTERNATIONAL, 37(6), 897-905, Jun. 2017, Not invited
Lead - NAFLDの病早期に肝線維化進行速度を予測することは可能か
藤森 尚之; 小松 通治; 田中 直樹; 杉浦 亜弓; 山崎 智生; 柴田 壮一郎; 市川 雪; 木村 岳史; 城下 智; 梅村 武司; 松本 晶博; 田中 榮司
肝臓, 58(Suppl.1), A445-A445, Apr. 2017
Lead - IL33/ST2 PATHWAY INVOLVEMENT IN THE PATHOGENESIS AND DISEASE PROGRESSION OF PRIMARY BILIARY CHOLANGITIS
Joshita, Satoru; Umemura, Takeji; Matsumoto, Akihiro; Yoshizawa, Kaname; Ota, Masao; Tanaka, Eiji
GASTROENTEROLOGY, 152(5), S1185-S1185, Apr. 2017
Lead - Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection
Takefumi Kimura; Akira Kobayashi; Naoki Tanaka; Kenji Sano; Michiharu Komatsu; Naoyuki Fujimori; Tomoo Yamazaki; Soichiro Shibata; Yuki Ichikawa; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Akira Horiuchi; Hiromitsu Mori; Shuichi Wada; Kendo Kiyosawa; Shin-ichi Miyagawa; Eiji Tanaka
HEPATOLOGY RESEARCH, 47(5), 405-418, Apr. 2017, Refereed, Not invited
Lead - Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
Yamazaki T; Joshita S; Umemura T; Usami Y; Sugiura A; Fujimori N; Shibata S; Ichikawa Y; Komatsu M; Matsumoto A; Igarashi K; Tanaka E
Sci Rep, 7, 46705, Apr. 2017, Not invited
Lead - Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population
Minae Kawashima; Yuki Hitomi; Yoshihiro Aiba; Nao Nishida; Kaname Kojima; Yosuke Kawai; Hitomi Nakamura; Atsushi Tanaka; Mikio Zeniya; Etsuko Hashimoto; Hiromasa Ohira; Kazuhide Yamamoto; Masanori Abe; Kazuhiko Nakao; Satoshi Yamagiwa; Shuichi Kaneko; Masao Honda; Takeji Umemura; Takafumi Ichida; Masataka Seike; Shotaro Sakisaka; Masaru Harada; Osamu Yokosuka; Yoshiyuki Ueno; Michio Senju; Tatsuo Kanda; Hidetaka Shibata; Takashi Himoto; Kazumoto Murata; Yasuhiro Miyake; Hirotoshi Ebinuma; Makiko Taniai; Satoru Joshita; Toshiki Nikami; Hajime Ota; Hiroshi Kouno; Hirotaka Kouno; Makoto Nakamuta; Nobuyoshi Fukushima; Motoyuki Kohjima; Tatsuji Komatsu; Toshiki Komeda; Yukio Ohara; Toyokichi Muro; Tsutomu Yamashita; Kaname Yoshizawa; Yoko Nakamura; Masaaki Shimada; Noboru Hirashima; Kazuhiro Sugi; Keisuke Ario; Eiichi Takesaki; Atsushi Naganuma; Hiroshi Mano; Haruhiro Yamashita; Kouki Matsushita; Kazuhiko Yamauchi; Fujio Makita; Hideo Nishimura; Kiyoshi Furuta; Naohiro Takahashi; Masahiro Kikuchi; Naohiko Masaki; Tomohiro Tanaka; Sumito Tamura; Akira Mori; Shintaro Yagi; Ken Shirabe; Atsumasa Komori; Kiyoshi Migita; Masahiro Ito; Shinya Nagaoka; Seigo Abiru; Hiroshi Yatsuhashi; Michio Yasunami; Shinji Shimoda; Kenichi Harada; Hiroto Egawa; Yoshihiko Maehara; Shinji Uemoto; Norihiro Kokudo; Hajime Takikawa; Hiromi Ishibashi; Kazuaki Chayama; Masashi Mizokami; Masao Nagasaki; Katsushi Tokunaga; Minoru Nakamura
HUMAN MOLECULAR GENETICS, 26(3), 650-659, Feb. 2017, Not invited
Lead - インターフェロン,核酸アナログ製剤の選択 : 適応と治療の実際 (特集 B型・C型肝炎の最新治療戦略 : どの治療を選択すべきか) -- (B型肝炎)
梅村 武司
消化器の臨床, 20(1), 20-23, Feb. 2017, Not invited
Lead - Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection
Yuki Ichikawa; Satoru Joshita; Takeji Umemura; Yugo Shobugawa; Yoko Usami; Soichiro Shibata; Tomoo Yamazaki; Naoyuki Fujimori; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka
HEPATOLOGY RESEARCH, 47(2), 226-233, Feb. 2017, Not invited
Lead - 【エキスパートが教える薬の使い方×エビデンスの調べ方】 (第1章)よくある疾患に対する薬の使い分け 肝炎
梅村武司; 田中榮司
薬事, 59(2), 280-284, Jan. 2017, Not invited
Lead - Association between endotoxemia and histological features of nonalcoholic fatty liver disease
Hiroyuki Kitabatake; Naoki Tanaka; Naoyuki Fujimori; Michiharu Komatsu; Ayaka Okubo; Kyogo Kakegawa; Takefumi Kimura; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Yuki Ichikawa; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Masayoshi Koinuma; Kenji Sano; Toshifumi Aoyama; Eiji Tanaka
WORLD JOURNAL OF GASTROENTEROLOGY, 23(4), 712-722, Jan. 2017, Not invited
Lead - Immunogenetics of IgG4-Related AIP
Masao Ota; Takeji Umemura; Shigeyuki Kawa
IGG4-RELATED DISEASE, 401, 35-44, 2017, Not invited
Lead - Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
Satoru Joshita; Takeji Umemura; Eiji Tanaka; Masao Ota
JOURNAL OF IMMUNOLOGY RESEARCH, -, 2017, Not invited
Lead - 全例SVRを目指したDAAs治療の選択
城下 智; 梅村 武司; 小松 通治; 山崎 智生; 藤森 尚之; 市川 雪; 柴田 壮一郎; 木村 岳史; 松本 晶博; 田中 榮司
肝臓, 57(Suppl.2), A542-A542, Sep. 2016
Lead - Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis
Naoyuki Fujimori; Naoki Tanaka; Soichiro Shibata; Kenji Sano; Tomoo Yamazaki; Tomohiro Sekiguchi; Hiroyuki Kitabatake; Yuki Ichikawa; Takefumi Kimura; Michiharu Komatsu; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
HEPATOLOGY RESEARCH, 46(10), 1019-1027, Sep. 2016, Not invited
Lead - Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C
Soichiro Shibata; Takeji Umemura; Tomoo Yamazaki; Naoyuki Fujimori; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka
HEPATOLOGY RESEARCH, 46(9), 884-889, Aug. 2016, Not invited
Lead - Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan
Kaname Yoshizawa; Satoru Joshita; Akihiro Matsumoto; Takeji Umemura; Eiji Tanaka; Susumu Morita; Toshitaka Maejima; Masao Ota
HEPATOLOGY RESEARCH, 46(9), 878-883, Aug. 2016, Not invited
Lead - Histopathology of IgG4-Related Autoimmune Hepatitis and IgG4-Related Hepatopathy in IgG4-Related Disease
Yasuni Nakanuma; Yoji Ishizu; Yoh Zen; Kenichi Harada; Takeji Umemura
SEMINARS IN LIVER DISEASE, 36(3), 229-241, Aug. 2016, Not invited
Lead - Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease
Soichiro Shibata; Satoru Joshita; Takeji Umemura; Tomoo Yamazaki; Naoyuki Fujimori; Yuki Ichikawa; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka
SPRINGERPLUS, 5, -, Jul. 2016, Not invited
Lead - Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan
Takeji Umemura; Satoru Joshita; Tomoo Yamazaki; Michiharu Komatsu; Yoshihiko Katsuyama; Kaname Yoshizawa; Eiji Tanaka; Masao Ota
SCIENTIFIC REPORTS, 6, -, Jul. 2016, Not invited
Lead - Severe Hepatotoxicity Associated With Asunaprevir and Daclatasvir in Chronic Hepatitis C
Soichiro Shibata; Takeji Umemura; Michiharu Komatsu; Eiji Tanaka
HEPATOLOGY, 63(6), 2063-2064, Jun. 2016, Not invited
Lead - A Case of Esophageal Hemangioma Successfully Treated by Endoscopic Injection Sclerotherapy
Suga Tomoaki, Okamura Takuma, Iwaya Yugo, Ito Tetsuya, Arakura Norikazu, Umemura Takeji, Tanaka Eiji
The Shinshu Medical Journal, 64(2), 75-78-78, Apr. 2016, Not invited
Lead - Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan
Kiyoaki Ito; Hiroshi Yotsuyanagi; Masaya Sugiyama; Hiroshi Yatsuhashi; Yoshiyasu Karino; Yasuhiro Takikawa; Takafumi Saito; Yasuji Arase; Fumio Imazeki; Masayuki Kurosaki; Takeji Umemura; Takafumi Ichida; Hidenori Toyoda; Masashi Yoneda; Yasuhito Tanaka; Eiji Mita; Kazuhide Yamamoto; Kojiro Michitaka; Tatsuji Maeshiro; Junko Tanuma; Masaaki Korenaga; Kazumoto Murata; Naohiko Masaki; Kazuhiko Koike; Masashi Mizokami
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31(1), 180-189, Jan. 2016, Not invited
Lead - Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease.
Hirayama A; Joshita S; Kitahara K; Mukawa K; Suga T; Umemura T; Tanaka E; Ota M
Dis Markers, 2016, 6485343, 2016, Not invited
Lead - IgG4関連自己免疫性肝炎および関連肝病変
中沼 安二; 石津 洋二; 全 陽; 原田 憲一; 梅村 武司
肝胆膵, 73(4), 551-558, 2016, Refereed, Not invited
Lead - Endoscopic Retrograde Cholangiopancreatography Using a Multi-bending Duodenoscope in Patients with a Billroth I Gastrectomy
Arakura Norikazu, Ito Tetsuya, Tanaka Eiji, Umemura Takeji
Shinshu Medical Journal, 63(6), 385-389, Dec. 2015
Lead - Treatment with the single-tablet regimen ledipasvir/sofosbuvir for 12weeks results in 100% sustained virologic response in Japanese patients with chronic genotype-1 hepatitis C virus infection
Masashi Mizokami; Tetsuo Takehara; Osamu Yokosuka; Naoya Sakamoto; Masaaki Korenaga; Hitoshi Mochizuki; Kunio Nakane; Hirayuki Enomoto; Mikio Yanase; Hidenori Toyoda; Fusao Ikeda; Takuya Genda; Takeji Umemura; Hiroshi Yatsuhashi; Tatsuya Ide; Nobuo Toda; Kazushige Nirei; Yoshiyuki Ueno; Yoichi Nishigaki; Juan Betular; Bing Gao; Akinobu Ishizaki; Masa Omote; Vivian Liu; Phillip S. Pang; Steven J. Knox; William T. Symonds; John G. Mchutchison; Namiki Izumi; Masao Omata
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 30, 372-373, Dec. 2015, Not invited
Lead - Factors associated with the effect of interferon-alpha sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B
Akihiro Matsumoto; Hiroshi Yatsuhashi; Shinya Nagaoka; Yoshiyuki Suzuki; Tetsuya Hosaka; Masataka Tsuge; Kazuaki Chayama; Tatsuo Kanda; Osamu Yokosuka; Shuhei Nishiguchi; Masaki Saito; Shiho Miyase; Jong-Hon Kang; Noboru Shinkai; Yasuhito Tanaka; Takeji Umemura; Eiji Tanaka
HEPATOLOGY RESEARCH, 45(12), 1195-1202, Dec. 2015, Not invited
Lead - Genetic factors affect the etiology, clinical characteristics and outcome of autoimmune hepatitis
Takeji Umemura; Masao Ota
Clinical Journal of Gastroenterology, 8(6), 360-366, Dec. 2015, Not invited
Lead - 長野県におけるC型肝炎に対するDAAs療法の現状について
小松 通治; 藤森 尚之; 柴田 壮一郎; 市川 雪; 木村 岳史; 松本 晶博; 吉澤 要; 梅村 武司; 田中 榮司
肝臓, 56(Suppl.2), A726-A726, Sep. 2015
Lead - 甲状腺機能異常はNAFLDの重症度・進行度に影響を与えるか
木村 岳史; 田中 直樹; 藤森 尚之; 柴田 壮一郎; 市川 雪; 城下 智; 小松 通治; 梅村 武司; 松本 晶博; 森 宏光; 和田 秀一; 田中 榮司
肝臓, 56(Suppl.2), A754-A754, Sep. 2015
Lead - 非侵襲的な検査の組み合わせによる食道胃静脈瘤の簡易予測モデルの作成
柴田 壮一郎; 松本 晶博; 藤森 尚之; 市川 雪; 木村 岳史; 小松 通治; 梅村 武司; 田中 榮司
肝臓, 56(Suppl.2), A778-A778, Sep. 2015
Lead - Primary hepatocellular carcinoma in a patient with neurofibromatosis type I
Takefumi Kimura; Naoki Tanaka; Takeji Umemura; Eiji Tanaka
LIVER INTERNATIONAL, 35(8), 2057-2058, Aug. 2015, Not invited
Lead - Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis
Takeji Umemura; Soichiro Shibata; Tomohiro Sekiguchi; Hiroyuki Kitabatake; Yuichi Nozawa; Sadahisa Okuhara; Takefumi Kimura; Susumu Morita; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka
HEPATOLOGY RESEARCH, 45(7), 739-744, Jul. 2015, Not invited
Lead - Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Masashi Mizokami; Osamu Yokosuka; Tetsuo Takehara; Naoya Sakamoto; Masaaki Korenaga; Hitoshi Mochizuki; Kunio Nakane; Hirayuki Enomoto; Fusao Ikeda; Mikio Yanase; Hidenori Toyoda; Takuya Genda; Takeji Umemura; Hiroshi Yatsuhashi; Tatsuya Ide; Nobuo Toda; Kazushige Nirei; Yoshiyuki Ueno; Yoichi Nishigaki; Juan Betular; Bing Gao; Akinobu Ishizaki; Masa Omote; Hongmei Mo; Kim Garrison; Phillip S. Pang; Steven J. Knox; William T. Symonds; John G. McHutchison; Namiki Izumi; Masao Omata
LANCET INFECTIOUS DISEASES, 15(6), 645-653, Jun. 2015, Refereed, Not invited
Lead - Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis
Tomohiro Sekiguchi; Takeji Umemura; Naoyuki Fujimori; Soichiro Shibata; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka; Masao Ota
PLOS ONE, 10(6), -, Jun. 2015, Not invited
Lead - Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis
Takeji Umemura; Satoru Joshita; Tomohiro Sekiguchi; Yoko Usami; Soichiro Shibata; Takefumi Kimura; Michiharu Komatsu; Akihiro Matsumoto; Masao Ota; Eiji Tanaka
AMERICAN JOURNAL OF GASTROENTEROLOGY, 110(6), 857-864, Jun. 2015, Not invited
Lead - 若年で発症した大腸癌多発肝転移の1例
藤森 尚之; 小松 通治; 北畠 央之; 野沢 祐一; 大工原 誠一; 柴田 壮一郎; 市川 雪; 木村 岳史; 梅村 武司; 松本 晶博; 田中 榮司
長野県医学会雑誌, 45, 18-19, Mar. 2015
Lead - Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPAR alpha
Michiharu Komatsu; Takefumi Kimura; Masahide Yazaki; Naoki Tanaka; Yang Yang; Takero Nakajima; Akira Horiuchi; Zhong-Ze Fang; Satoru Joshita; Akihiro Matsumoto; Takeji Umemura; Eiji Tanaka; Frank J. Gonzalez; Shu-Ichi Ikeda; Toshifumi Aoyama
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1852(3), 473-481, Mar. 2015, Not invited
Lead - Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.
Nagaya T; Tanaka N; Kimura T; Kitabatake H; Fujimori N; Komatsu M; Horiuchi A; Yamaura T; Umemura T; Sano K; Gonzalez FJ; Aoyama T; Tanaka E
BBA Clin, 3, 168-74, Feb. 2015, Not invited
Lead - Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA
Polychronis Pavlidis; Zakera Shums; Andreas L. Koutsoumpas; Jay Milo; Maria Papp; Takeji Umemura; Peter L. Lakatos; Daniel S. Smyk; Dimitrios P. Bogdanos; Alastair Forbes; Gary L. Norman
CLINICA CHIMICA ACTA, 441, 176-181, Feb. 2015, Not invited
Lead - Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion
Nozomi Kamijo; Akihiro Matsumoto; Takeji Umemura; Soichiro Shibata; Yuki Ichikawa; Takefumi Kimura; Michiharu Komatsu; Eiji Tanaka
WORLD JOURNAL OF GASTROENTEROLOGY, 21(2), 541-548, Jan. 2015, Not invited
Lead - 国内におけるde novo B型肝炎の実態と肝臓学会によるB型肝炎治療ガイドライン
梅村 武司
血液内科, 70(1), 123-127, Jan. 2015, Not invited
Lead - Ｃ型肝炎の新規治療法
梅村 武司
信州医学雑誌, 63(6), 367-374, 2015, Not invited
Lead - Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis
Yasuhiro Miyake; Kazuhide Yamamoto; Hiroshi Matsushita; Masanori Abe; Atsushi Takahashi; Takeji Umemura; Atsushi Tanaka; Makoto Nakamuta; Yasunari Nakamoto; Yoshiyuki Ueno; Toshiji Saibara; Hajime Takikawa; Kaname Yoshizawa; Hiromasa Ohira; Mikio Zeniya; Morikazu Onji; Hirohito Tsubouchi
HEPATOLOGY RESEARCH, 44(13), 1299-1307, Dec. 2014, Not invited
Lead - AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis
Satoru Joshita; Takeji Umemura; Masao Ota; Eiji Tanaka
JOURNAL OF HEPATOLOGY, 61(6), 1443-1445, Dec. 2014, Not invited
Lead - Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
Masao Omata; Shuhei Nishiguchi; Yoshiyuki Ueno; Hitoshi Mochizuki; Namiki Izumi; Fusao Ikeda; Hidenori Toyoda; Osamu Yokosuka; Kazushige Nirei; Takuya Genda; Takeji Umemura; Tetsuo Takehara; Naoya Sakamoto; Yoichi Nishigaki; Kunio Nakane; Nobuo Toda; Tatsuya Ide; Mikio Yanase; Keisuke Hino; Bing Gao; Kimberly L. Garrison; Hadas Dvory-Sobol; Akinobu Ishizaki; Masa Omote; Diana Brainard; Steven Knox; William T. Symonds; John G. McHutchison; Hiroshi Yatsuhashi; Masashi Mizokami
JOURNAL OF VIRAL HEPATITIS, 21(11), 762-768, Nov. 2014, Refereed, Not invited
Lead - 多腺性自己免疫症候群3型と自己免疫性肝炎
木村 岳史; 梅村 武司; 田中 榮司
肝臓, 55(Suppl.3), A790-A790, Oct. 2014
Lead - 32年の経過で脂肪肝から肝硬変への進展が組織学的に確認できた非アルコール性脂肪性肝炎(NASH)の1例
一條 哲也; 樋口 和男; 須藤 貴森; 張 淑美; 望月 太郎; 木村 岳史; 小松 通治; 梅村 武司; 田中 榮司
肝臓, 55(Suppl.3), A833-A833, Oct. 2014
Lead - Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B
Okuhara S, Umemura T, Joshita S, Shibata S, Kimura T, Morita S, Komatsu M, Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E
Hepatol Res, 44(10), E172-80, Oct. 2014
Lead - Characteristics and prediction of hepatitis B e-antigen negative hepatitis following seroconversion in patients with chronic hepatitis B
Susumu Morita; Akihiro Matsumoto; Takeji Umemura; Soichiro Shibata; Nozomi Kamijo; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Michiharu Komatsu; Kaname Yoshizawa; Eiji Tanaka
HEPATOLOGY RESEARCH, 44(10), E45-E53, Oct. 2014, Refereed, Not invited
Lead - KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C
Takeji Umemura; Masao Ota; Yoshihiko Katsuyama; Shuichi Wada; Hiromitsu Mori; Atsushi Maruyama; Soichiro Shibata; Yuichi Nozawa; Takefumi Kimura; Susumu Morita; Satoru Joshita; Michiharu Komatsu; Akihiro Matsumoto; Atsushi Kamijo; Masakazu Kobayashi; Masato Takamatsu; Kaname Yoshizawa; Kendo Kiyosawa; Eiji Tanaka
HUMAN IMMUNOLOGY, 75(8), 822-826, Aug. 2014, Not invited
Lead - 血小板減少症に対する部分的脾塞栓術・脾摘後にインターフェロン治療を受けたC型肝硬変例の長期予後
森田 進; 松本 晶博; 梅村 武司; 柴田 壮一郎; 市川 雪; 木村 岳史; 城下 智; 小松 通治; 田中 榮司
日本門脈圧亢進症学会雑誌, 20(2), 122-125, Jul. 2014
Lead - Laparoscopic findings of congenital hepatic fibrosis: A case report and review of the published work
Michiharu Komatsu; Naoki Tanaka; So-Ichirou Shibata; Takefumi Kimura; Yuki Ichikawa; Susumu Morita; Satoru Joshita; Tadanobu Nagaya; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Eiji Tanaka
HEPATOLOGY RESEARCH, 44(7), 818-824, Jul. 2014, Not invited
Lead - HLA CLASS II HAPLOTYPES AFFECT CLINICAL CHARACTERISTICS AND PROGRESSION OF TYPE 1 AUTOIMMUNE HEPATITIS IN JAPAN
Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Inoko, Hidetoshi; Ota, Masao
TISSUE ANTIGENS, 84(1), 153-153, Jul. 2014, Not invited
Lead - Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
Takeji Umemura; Yoshihiko Katsuyama; Kaname Yoshizawa; Takefumi Kimura; Satoru Joshita; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka; Masao Ota
PLOS ONE, 9(6), Jun. 2014, Not invited
Lead - Natural History and Prognosis of Asymptomatic and Symptomatic Japanese Patients With Primary Biliary Cirrhosis: Results of a Median 9-Year Follow-Up Study
Joshita, Satoru; Umemura, Takeji; Nozawa, Yuichi; Okuhara, Sadahisa; Shibata, Soichiro; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Yoshizawa, Kaname; Ota, Masao; Tanaka, Eiji
GASTROENTEROLOGY, 146(5), S906-S906, May 2014
Lead - C型肝炎における肝線維化進展をどう評価し治療するか C型慢性肝炎における非侵襲的肝線維化マーカーと複数回肝生検による肝線維化進行度の評価
梅村 武司; 森田 進; 柴田 壮一郎; 市川 雪; 木村 岳史; 小松 通治; 松本 晶博; 田中 榮司
肝臓, 55(Suppl.1), A106-A106, Apr. 2014
Lead - 成人発症II型シトルリン血症における脂肪肝の形成機序
木村 岳史; 小松 通治; 矢崎 正英; 柴田 壮一郎; 市川 雪; 森田 進; 梅村 武司; 松本 晶博; 池田 修一; 田中 榮司; 青山 俊文
肝臓, 55(Suppl.1), A325-A325, Apr. 2014
Lead - Genetic polymorphism in IFNL4 and response to pegylated interferon-alpha and ribavirin in Japanese chronic hepatitis C patients
Nozawa Y, Umemura T, Katsuyama Y, Shibata S, Kimura T, Morita S, Joshita S, Komatsu M, Matsumoto A, Yoshizawa K, Ota M, Tanaka E
Shinshu Medical Journal, 83(1), 45-8-8, Jan. 2014
Lead - Risk Factors for Long-Term Persistence of Serum Hepatitis B Surface Antigen Following Acute Hepatitis B Virus Infection in Japanese Adults
Kiyoaki Ito; Hiroshi Yotsuyanagi; Hiroshi Yatsuhashi; Yoshiyasu Karino; Yasuhiro Takikawa; Takafumi Saito; Yasuji Arase; Fumio Imazeki; Masayuki Kurosaki; Takeji Umemura; Takafumi Ichida; Hidenori Toyoda; Masashi Yoneda; Eiji Mita; Kazuhide Yamamoto; Kojiro Michitaka; Tatsuji Maeshiro; Junko Tanuma; Yasuhito Tanaka; Masaya Sugiyama; Kazumoto Murata; Naohiko Masaki; Masashi Mizokami
HEPATOLOGY, 59(1), 89-97, Jan. 2014, Not invited
Lead - 97% Sustained Virologic Response in Japanese Patients with Chronic Genotype 2 Hepatitis C Virus Infection Receiving Sofosbuvir in Combination with Ribavirin for 12 Weeks: Results from a Phase 3 Multicenter Study
Omata, Masao; Nishiguchi, Shuhei; Ueno, Yoshiyuki; Mochizuki, Hitoshi; Izumi, Namiki; Ikeda, Fusao; Toyoda, Hidenori; Yokosuka, Osamu; Nirei, Kazushige; Genda, Takuya; Umemura, Takeji; Takehara, Tetsuo; Sakamoto, Naoya; Nishigaki, Yoichi; Nakane, Kunio; Toda, Nobuo; Ide, Tatsuya; Yanase, Mikio; Hino, Keisuke; Betular, Juan; Gao, Bing; Ishizaki, Akinobu; Omote, Masa; Brainard, Diana M.; Knox, Steven J.; Symonds, William T.; McHutchison, John G.; Yatsuhashi, Hiroshi; Mizokami, Masashi
HEPATOLOGY, 60, 671A-671A, 2014
Lead - 100% SVR4 in Japanese Patients with Chronic Genotype 1 Hepatitis C Virus Infection Receiving Ledipasvir/Sofosbuvir Fixed Dose Combination for 12 Weeks: Results from a Multicenter Phase 3 Study
Mizokami, Masashi; Takehara, Tetsuo; Yokosuka, Osamu; Sakamoto, Naoya; Korenaga, Masaaki; Mochizuki, Hitoshi; Nakane, Kunio; Enomoto, Hirayuki; Yanase, Mikio; Toyoda, Hidenori; Ikeda, Fusao; Genda, Takuya; Umemura, Takeji; Yatsuhashi, Hiroshi; Ide, Tatsuya; Toda, Nobuo; Nirei, Kazushige; Ueno, Yoshiyuki; Nishigaki, Yoichi; Betular, Juan; Gao, Bing; Ishizaki, Akinobu; Omote, Masa; Pang, Phillip S.; Knox, Steven J.; Symonds, William T.; McHutchison, John G.; Izumi, Namiki; Omata, Masao
HEPATOLOGY, 60, 1130A-1130A, 2014
Lead - 共通生薬成分を含む漢方薬の再投与により薬物性肝障害再発をきたした1例
丸山 康弘,吉澤 要,鶴田 史,丸山 雅史,藤森 一也,滋野 俊,福島 万奈,上原 剛,森田 進,城下 智,梅村 武司,田中 榮司
Shinshu Medical Journal, 55(4), 214-220-220, 2014, Not invited
Lead - STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
Satoru Joshita; Takeji Umemura; Minoru Nakamura; Yoshihiko Katsuyama; Soichiro Shibata; Takefumi Kimura; Susumu Morita; Michiharu Komatsu; Akihiro Matsumoto; Kaname Yoshizawa; Hiromi Ishibashi; Eiji Tanaka; Masao Ota
DISEASE MARKERS, 2014, 727393, 2014, Not invited
Lead - KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan
Yuichi Nozawa; Takeji Umemura; Satoru Joshita; Yoshihiko Katsuyama; Soichiro Shibata; Takefumi Kimura; Susumu Morita; Michiharu Komatsu; Akihiro Matsumoto; Eiji Tanaka; Masao Ota
PLOS ONE, 8(12), Dec. 2013, Not invited
Lead - de novo B型肝炎のウイルス学的特徴 (特集 B型肝炎ウイルス再活性化の現状と対策)
梅村 武司
消化器内科, 57(5), 624-626, Nov. 2013, Not invited
Lead - de novo B型肝炎のウイルス学的特徴 (特集 B型肝炎ウイルス再活性化の現状と対策)
梅村 武司
消化器内科, 57(5), 624-626, Nov. 2013
Lead - KIR, HLA, and a genetic variant of IL28B are associated with a virological response to PEG-IFN/RBV therapy for chronic hepatitis C
Umemura, Takeji; Nozawa, Yuichi; Joshita, Satoru; Katsuyama, Yoshihiko; Tanaka, Eiji; Ota, Masao
HEPATOLOGY, 58, 1151A-1151A, Oct. 2013
Lead - Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy
Satoru Joshita; Kumiko Shirahata; Yoshikazu Yazaki; Shinji Okaniwa; Yoshiyuki Nakamura; Takefumi Kimura; Sugiko Noami; Reiko Horigome; Hikaru Yagi; Nobuo Ito; Asami Yamazaki; Yuki Akahane; Takeji Umemura; Kaname Yoshizawa; Eiji Tanaka; Masao Ota
HEPATOLOGY RESEARCH, 43(7), 801-807, Jul. 2013, Not invited
Lead - 乳び腹水に対してオクトレオチド投与が有効であった子宮頸癌, 肝細胞癌合併C型肝硬変の1例
齊藤 博美; 城下 智; 吉澤 要; 藤森 芳史; 丸山 康弘; 伊藤 哲也; 児玉 亮; 横沢 秀一; 小松 通治; 梅村 武司; 田中 榮司
肝臓, 54(4), 284-290, Apr. 2013, Not invited
Lead - 高齢者のC型肝炎に対する3剤併用療法の有効性の検討
柴田 壮一郎; 梅村 武司; 木村 岳史; 森田 進; 城下 智; 小松 通治; 松本 晶博; 吉澤 要; 丸山 敦史; 森 宏光; 和田 秀一; 清澤 研道; 田中 榮司
肝臓, 54(Suppl.1), A347-A347, Apr. 2013
Lead - Entecavir治療中におけるB型慢性肝炎患者の血清サイトカイン、ケモカインの検討
奥原 禎久; 梅村 武司; 城下 智; 柴田 壮一郎; 木村 岳史; 森田 進; 小松 通治; 松本 晶博; 吉澤 要; 田中 榮司
肝臓, 54(Suppl.1), A407-A407, Apr. 2013
Lead - 本邦におけるde novo B型肝炎症例の背景と予後 (特集 B型肝炎再活性化の現状と対策 : 肝臓,血液,リウマチ,腫瘍領域の現状を踏まえて)
梅村 武司
最新医学, 68(3), 351-354-345, Mar. 2013, Not invited
Lead - Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis
Susumu Morita; Satoru Joshita; Takeji Umemura; Yoshihiko Katsuyama; Takefumi Kimura; Michiharu Komatsu; Akihiro Matsumoto; Kaname Yoshizawa; Astushi Kamijo; Nobuyoshi Yamamura; Eiji Tanaka; Masao Ota
HUMAN IMMUNOLOGY, 74(2), 219-222, Feb. 2013, Not invited
Lead - Liver Dysfunction and Thrombocytopenia Diagnosed as Intravascular Large B-cell Lymphoma Using a Timely and Accurate Transjugular Liver Biopsy
Nodoka Sekiguchi; Satoru Joshita; Toshikazu Yoshida; Masahiro Kurozumi; Kenji Sano; Michitaka Nakagawa; Tetsuya Ito; Tsuyoshi Matsushita; Daisuke Komatsu; Michiharu Komatsu; Toshiro Ito; Takeji Umemura; Shu-ichi Ikeda; Masumi Kadoya; Fumihiro Ishida; Eiji Tanaka
INTERNAL MEDICINE, 52(17), 1903-1908, 2013, Not invited
Lead - C型慢性肝疾患におけるインターフェロン治療によりSVRが得られた肝細胞癌合併症例の検討
森田 進; 松本 晶博; 吉澤 要; 小松 通治; 城下 智; 柴田 荘一郎; 市川 雪; 木村 岳史; 梅村 武司; 田中 榮司
肝臓, 53(Suppl.3), A937-A937, Oct. 2012
Lead - Viral Factors of Patients with Fulminant Hepatic Failure Due to Hepatitis B Virus Reactivation from HBsAg-negative Status
Umemura, Takeji; Ota, Masao; Katsuyama, Yoshihiko; Joshita, Satoru; Kiyosawa, Kendo; Tanaka, Eiji
HEPATOLOGY, 56, 634A-635A, Oct. 2012
Lead - Signal transducer and activator of transcription 4 gene polymorphisms are associated with production of antinuclear antibody in Japanese patients with primary biliary cirrhosis
Joshita, Satoru; Umemura, Takeji; Nakamura, Minoru; Katsuyama, Yoshihiko; Yoshizawa, Kaname; Tanaka, Eiji; Ota, Masao
HEPATOLOGY, 56, 1134A-1135A, Oct. 2012
Lead - HLA DRB1*09:01-DQB1*03:03 haplotype is Associated with Progression of Primary Biliary Cirrhosis
Umemura, Takeji; Joshita, Satoru; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Ota, Masao
HEPATOLOGY, 56, 1142A-1142A, Oct. 2012
Lead - HLA class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis.
Umemura T, Joshita S, Ichijo T, Yoshizawa K, Katsuyama Y, Tanaka E, Ota M; The Shinshu PBC Study Group.
HEPATOLOGY, 56, 1142A-1142A, Oct. 2012
Lead - Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
Minoru Nakamura; Nao Nishida; Minae Kawashima; Yoshihiro Aiba; Atsushi Tanaka; Michio Yasunami; Hitomi Nakamura; Atsumasai Komori; Makoto Nakamuta; Mikio Zeniya; Etsuko Hashimoto; Hiromasa Ohira; Kazuhide Yamamoto; Morikazu Onji; Shuichi Kaneko; Masao Honda; Satoshi Yamagiwa; Kazuhiko Nakao; Takafumi Ichida; Hajime Takikawa; Masataka Seike; Takeji Umemura; Yoshiyuki Ueno; Shotaro Sakisaka; Kentaro Kikuchi; Hirotoshi Ebinuma; Noriyo Yamashiki; Sumito Tamura; Yasuhiko Sugawara; Akira Mori; Shintaro Yagi; Ken Shirabe; Akinobu Taketomi; Kuniaki Arai; Kyoko Monoe; Tatsuki Ichikawa; Makiko Taniai; Yasuhiro Miyake; Teru Kumagi; Masanori Abe; Kaname Yoshizawa; Satoru Joshita; Shinji Shimoda; Koichi Honda; Hiroki Takahashi; Katsuji Hirano; Yasuaki Takeyama; Kenichi Harada; Kiyoshi Migita; Masahiro Ito; Hiroshi Yatsuhashi; Nobuyoshi Fukushima; Hajime Ota; Tatsuji Komatsu; Takeo Saoshiro; Jinya Ishida; Hirotsugu Kouno; Hirotaka Kouno; Michiyasu Yagura; Masakazu Kobayashi; Toyokichi Muro; Naohiko Masaki; Keiichi Hirata; Yukio Watanabe; Yoko Nakamura; Masaaki Shimada; Noboru Hirashima; Toshiki Komeda; Kazuhiro Sugi; Michiaki Koga; Keisuke Ario; Eiichi Takesaki; Yoshihiko Maehara; Shinji Uemoto; Norihiro Kokudo; Hirohito Tsubouchi; Masashi Mizokami; Yasuni Nakanuma; Katsushi Tokunaga; Hiromi Ishibashi
AMERICAN JOURNAL OF HUMAN GENETICS, 91(4), 721-728, Oct. 2012, Not invited
Lead - 高齢C型肝炎患者の実情とpeginterferon+ribavirin少量併用療法の有用性
松本 晶博; 市川 雪; 梅村 武司; 小松 通治; 城下 智; 森田 進; 木村 岳史; 田中 榮司
肝臓, 53(Suppl.2), A692-A692, Sep. 2012
Lead - 2型糖尿病合併NAFLD/NASHに対するミグリトールの有用性の検討
小松 通治; 木村 岳史; 田中 直樹; 梅村 武司; 田中 榮次
肝臓, 53(Suppl.2), A707-A707, Sep. 2012
Lead - Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
Akihiro Matsumoto; Eiji Tanaka; Susumu Morita; Kaname Yoshizawa; Takeji Umemura; Satoru Joshita
JOURNAL OF GASTROENTEROLOGY, 47(9), 1006-1013, Sep. 2012, Not invited
Lead - 血小板減少症に対するPSE・脾摘後にIFN療法を受けたC型肝硬変例の長期予後
森田 進; 松本 晶博; 市川 雪; 城下 智; 柴田 壮一郎; 木村 岳史; 小松 通治; 梅村 武司; 吉澤 要; 田中 榮司
日本門脈圧亢進症学会雑誌, 18(3), 82-82, Aug. 2012
Lead - Long-term outcome of Japanese patients with type 1 autoimmune hepatitis
Kaname Yoshizawa; Akihiro Matsumoto; Tetsuya Ichijo; Takeji Umemura; Satoru Joshita; Michiharu Komatsu; Naoki Tanaka; Eiji Tanaka; Masao Ota; Yoshihiko Katsuyama; Kendo Kiyosawa; Masanori Abe; Morikazu Onji
HEPATOLOGY, 56(2), 668-676, Aug. 2012, Not invited
Lead - Clinical Characteristics of Young-Onset Ischemic Colitis
Takefumi Kimura; Akihiro Shinji; Akira Horiuchi; Naoki Tanaka; Tadanobu Nagaya; Takashi Shigeno; Naoshi Nakamura; Michiharu Komatsu; Takeji Umemura; Norikazu Arakura; Akihiro Matsumoto; Eiji Tanaka
DIGESTIVE DISEASES AND SCIENCES, 57(6), 1652-1659, Jun. 2012, Not invited
Lead - B型肝炎 HBe抗原が陰性である慢性B型肝炎の発症の因子についての検討
森田 進; 松本 晶博; 上条 のぞみ; 市川 雪; 木村 岳史; 城下 智; 小松 通治; 梅村 武司; 吉澤 要; 田中 榮司
肝臓, 53(Suppl.1), A325-A325, Apr. 2012
Lead - インターフェロン治療にてウイルス学的著効(SVR)となったが、その後17年を経て肝細胞癌(HCC)を発症したC型慢性肝炎の一例
小澤 若菜; 森田 進; 城下 智; 奥原 禎久; 市川 雪; 木村 岳史; 小松 通治; 梅村 武司; 一條 哲也; 松本 晶博; 田中 榮司
長野県医学会雑誌, 42, 92-93, Mar. 2012
Lead - Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
Satoru Joshita; Takeji Umemura; Yoshihiko Katsuyama; Yuki Ichikawa; Takefumi Kimura; Susumu Morita; Atsushi Kamijo; Michiharu Komatsu; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Nozomi Kamijo; Masao Ota; Eiji Tanaka
HUMAN IMMUNOLOGY, 73(3), 298-300, Mar. 2012, Not invited
Lead - Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis
Takeji Umemura; Satoru Joshita; Tetsuya Ichijo; Kaname Yoshizawa; Yoshihiko Katsuyama; Eiji Tanaka; Masao Ota
HEPATOLOGY, 55(2), 506-511, Feb. 2012, Not invited
Lead - B型肝炎 universal vaccination へ向けて
四柳 宏; 田中 靖人; 齋藤 昭彦; 梅村 武司; 伊藤 清顕; 柘植 雅貴; 高橋 祥一; 中西 裕之; 吉田 香奈子; 世古口 悟; 高橋 秀明; 林 和彦; 田尻 仁; 小松 陽樹; 菅内 文中; 田尻 和人; 上田 佳秀; 奥瀬 千晃; 八橋 弘; 溝上 雅史
肝臓, 53(2), 117-130, Feb. 2012, Not invited
Lead - CLINICAL AND VIROLOGICAL FACTORS OF PATIENTS WITH FULMINANT HEPATIC FAILURE DUE TO HEPATITIS B VIRUS REACTIVATION FROM HBSAG-NEGATIVE STATUS
Umemura, Takeji; Kiyosawa, Kendo; Katsuyama, Yoshihiko; Ota, Masao; Tanaka, Eiji
HEPATOLOGY, 54, 879A-879A, Oct. 2011
Lead - Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients.
Aiba Y; Nakamura M; Joshita S; Inamine T; Komori A; Yoshizawa K; Umemura T; Horie H; Migita K; Yatsuhashi H; Nakamuta M; Fukushima N; Saoshiro T; Hayashi S; Kouno H; Ota H; Muro T; Watanabe Y; Nakamura Y; Komeda T; Shimada M; Masaki N; Komatsu T; Yagura M; Sugi K; Koga M; Tsukamoto K; Tanaka E; Ishibashi H; PBC Study Group in NHOSLJ
Journal of gastroenterology, 46(10), 1203-1212, Oct. 2011, Refereed, Not invited
Lead - 長野県における非B非C肝硬変の成因別実態
木村 岳史; 梅村 武司; 田中 榮司
肝臓, 52(Suppl.2), A454-A454, Sep. 2011
Lead - Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy
Yuki Ichikawa-Yamada; Satoru Joshita; Yoshinori Tsukahara; Takefumi Kimura; Susumu Morita; Atsushi Kamijo; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Eiji Tanaka
HEPATOLOGY RESEARCH, 41(9), 904-909, Sep. 2011, Not invited
Lead - 人間ドック・健康診断を含む肝機能検査値異常と原発性胆汁性肝硬変の診断および病期・病態との関連
城下 智; 山田 雪; 木村 岳史; 森田 進; 小松 通治; 梅村 武司; 一條 哲也; 松本 晶博; 吉澤 要; 田中 榮司
人間ドック, 26(2), 262-262, Jul. 2011
Lead - Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
Suguru Yoneda; Takeji Umemura; Satoru Joshita; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Yoshihiko Katsuyama; Masao Ota; Eiji Tanaka
HEPATOLOGY RESEARCH, 41(6), 587-593, Jun. 2011, Not invited
Lead - Occult HBV感染とその対応 (新時代のウイルス性肝炎学--基礎・臨床研究の進歩) -- (特殊な病態におけるB型肝炎に対する対応)
梅村 武司
日本臨床, 69(増刊4 新時代のウイルス性肝炎学), 515-519-301, May 2011, Not invited
Lead - B型肝炎の発症機序と病態 (新時代のウイルス性肝炎学--基礎・臨床研究の進歩) -- (B型肝炎の病態)
田中 榮司,松本 晶博,梅村 武司
日本臨床, 69, 417-421-421, May 2011, Not invited
Last - B型肝炎長期経過観察例におけるプレコア・コアプロモーター変異と各種HBVマーカーとの関係
松本 晶博; 森田 進; 山田 雪; 木村 岳史; 上條 敦; 城下 智; 梅村 武司; 一條 哲也; 吉澤 要; 田中 榮司
肝臓, 52(Suppl.1), A182-A182, Apr. 2011
Lead - IL-28B遺伝子多型と臨床病態および治療効果との検討
城下 智; 梅村 武司; 山田 雪; 木村 岳史; 森田 進; 上條 敦; 一條 哲也; 松本 晶博; 吉澤 要; 田中 榮司
肝臓, 52(Suppl.1), A211-A211, Apr. 2011
Lead - 高齢肝細胞癌患者に対するTACE治療の実態
一條 哲也; 山田 雪; 木村 岳史; 森田 進; 上條 敦; 城下 智; 小松 通治; 梅村 武司; 松本 晶博; 田中 榮司
肝臓, 52(Suppl.1), A344-A344, Apr. 2011
Lead - 肝生検の重篤な合併症の現状と背景疾患
木村 岳史; 城下 智; 市川 雪; 奥原 禎久; 森田 進; 上條 敦; 小松 通治; 梅村 武司; 一條 哲也; 松本 晶博; 田中 榮司
肝臓, 52(Suppl.1), A439-A439, Apr. 2011
Lead - Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients
Kamijo A; Yoshizawa K; Joshita S; Yoneda S; Umemura T; Ichijo T; Matsumoto A; Ota M; Tanaka E
HEPATOLOGY RESEARCH, 41(4), 350-357-357, Apr. 2011, Not invited
Lead - 【自己免疫性胆管疾患のオーバーラップス PBC/AIH、PSC/AIHとPSC/IgG4関連硬化性胆管炎を中心に】 PSCとその類縁疾患、オーバーラップス 疫学・臨床・病理 IgG4関連硬化性胆管炎の肝実質障害とIgG4関連AIH
浜野英明; 梅村武司; 田中榮司
肝・胆・膵, 62(4), 813-816, Apr. 2011, Not invited
Lead - Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients
Suguru Yoneda; Takeji Umemura; Yoshihiko Katsuyama; Atsushi Kamijo; Satoru Joshita; Michiharu Komatsu; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Masao Ota; Eiji Tanaka
JOURNAL OF INFECTIOUS DISEASES, 203(8), 1087-1095, Apr. 2011, Not invited
Lead - ソラフェニブの投与が有効であった、転移を伴う肝細胞癌の2症例
城下 智; 上條 敦; 山田 雪; 木村 岳史; 森田 進; 梅村 武司; 一條 哲也; 松本 晶博; 吉澤 要; 田中 榮司
長野県医学会雑誌, 41, 79-81, Mar. 2011
Lead - Clinical significance of immunoglobulin G4-associated autoimmune hepatitis
Takeji Umemura; Yoh Zen; Hideaki Hamano; Satoru Joshita; Tetsuya Ichijo; Kaname Yoshizawa; Kendo Kiyosawa; Masao Ota; Shigeyuki Kawa; Yasuni Nakanuma; Eiji Tanaka
JOURNAL OF GASTROENTEROLOGY, 46(S1), 48-55, Jan. 2011, Not invited
Lead - Genetic background of autoimmune hepatitis in Japan
Kaname Yoshizawa; Takeji Umemura; Masao Ota
JOURNAL OF GASTROENTEROLOGY, 46(1), 42-47, Jan. 2011, Not invited
Lead - Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C
Takeji Umemura; Satoru Joshita; Suguru Yoneda; Yoshihiko Katsuyama; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Masao Ota; Eiji Tanaka
ANTIVIRAL THERAPY, 16(7), 1073-1080, 2011, Not invited
Lead - Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population
Masao Ota; Tetsuya Ito; Takeji Umemura; Yoshihiko Katsuyama; Kaname Yoshizawa; Hideaki Hamano; Shigeyuki Kawa
DISEASE MARKERS, 31(4), 223-229, 2011, Not invited
Lead - A Case of Pyogenic Liver Abscess Infected with Fusobacterium necrophorum Depicted by Microscopy and Confirmed by Tissue Culture
Yuichi Nozawa; Satoru Joshita; Mana Fukushima; Yukiko Sugiyama; Yuki Ichikawa; Takefumi Kimura; Susumu Morita; Atsushi Kamijo; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Eiji Tanaka
INTERNAL MEDICINE, 50(17), 1815-1819, 2011, Not invited
Lead - Severe hepatic encephalopathy and decrease in enhancement of hepatocellular carcinoma treated with sorafenib
Kimura T; Umemura T; Ichijo T; Yamamura N; Tanaka E
International Journal of Case Reports and Images, 1(4), 16-18, Dec. 2010, Not invited
Lead - 免疫抑制・化学療法中に発生するde novo B型肝炎 (特集 B型肝炎ウイルス再活性化の問題点と対策)
梅村 武司
消化器内科, 51(4), 386-390-427, Oct. 2010, Not invited
Lead - Sorafenib投与3日間で著明な抗腫瘍効果を認めたが、肝性脳症を発症し死亡した肝細胞癌の1例
木村 岳史; 進士 明宏; 小松 健一; 太田 裕志; 武川 建二; 山村 伸吉; 小松 通治; 梅村 武司; 一條 哲也; 田中 榮司
肝臓, 51(Suppl.2), A567-A567, Sep. 2010
Lead - Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients
Satoru Joshita; Takeji Umemura; Kaname Yoshizawa; Yoshihiko Katsuyama; Eiji Tanaka; Minoru Nakamura; Hiromi Ishibashi; Masao Ota
JOURNAL OF HEPATOLOGY, 53(3), 537-541, Sep. 2010, Not invited
Lead - Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment
Yasushi Tamura; Masato Igarashi; Takeshi Suda; Toshifumi Wakai; Yoshio Shirai; Takeji Umemura; Eiji Tanaka; Satoru Kakizaki; Hitoshi Takagi; Yoichi Hiasa; Morikazu Onji; Yutaka Aoyagi
DIGESTIVE DISEASES AND SCIENCES, 55(7), 2095-2101, Jul. 2010, Not invited
Lead - Another Cause of Autoimmune Hepatitis
Takeji Umemura; Yoh Zen; Yasuni Nakanuma; Kendo Kiyosawa
HEPATOLOGY, 52(1), 389-390, Jul. 2010, Not invited
Lead - Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
Masaru Tsutsui; Naoki Tanaka; Masatomo Kawakubo; Yo Sheena; Akira Horiuchi; Michiharu Komatsu; Tadanobu Nagaya; Satoru Joshita; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Toshifumi Aoyama; Eiji Tanaka; Kenji Sano
JOURNAL OF CLINICAL GASTROENTEROLOGY, 44(6), 440-447, Jul. 2010, Not invited
Lead - Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits
Goro Tsuruta; Naoki Tanaka; Minoru Hongo; Michiharu Komatsu; Akira Horiuchi; Kaeko Hamamoto; Chieko Iguchi; Yoshiko Nakayama; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Toshifumi Aoyama; Eiji Tanaka
JOURNAL OF GASTROENTEROLOGY, 45(6), 666-672, Jun. 2010, Not invited
Lead - A Novel Heterophilic Antibody Interaction Involves IgG4
T. Ito; K. Kitahara; T. Umemura; M. Ota; Y. Shimozuru; S. Kawa; S. Bahram
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 71(2), 109-114, Feb. 2010, Not invited
Lead - A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients
Joshita S, Umemura T, Yoshizawa K, Katsuyama Y, Tanaka E, Ota M, the Shinshu PBC Study Group
HUMAN IMMUNOLOGY, 71(5), 520-524, 2010
Lead - Comparison of hepatitis B virus DNA, RNA, and core related antigen as predictors of lamivudine resistance in patients with chronic hepatitis B
Matsumoto A; Maki N; Yoshizawa K; Umemura T; Joshita S; Tanaka E
ShinshuMed J, 58(4), 153-162, 2010, Not invited
Lead - DOWN-REGULATION OF SREBP-1C IS ASSOCIATED WITH THE DEVELOPMENT OF BURNED-OUT NASH
T. Nagaya; N. Tanaka; M. Komatsu; S. Joshita; T. Umemura; T. Ichijo; A. Matsumoto; K. Yoshizawa; T. Aoyama; E. Tanaka
JOURNAL OF HEPATOLOGY, 52(0), S373-S374, 2010, Not invited
Lead - CLINICAL AND VIROLOGICAL FEATURES OF PATIENTS WITH FULMINANT HEPATIC FAILURE DUE TO HEPATITIS B VIRUS REACTIVATION FROM HBSAG-NEGATIVE STATUS
T. Umemura; K. Kiyosawa; E. Tanaka; Japan Novo Hepatitis B. Res Grp
JOURNAL OF HEPATOLOGY, 52, S286-S286, 2010, Not invited
Lead - ATAXIN 2-BINDING PROTEIN 1 AS A NOVEL SUSCEPTIBLE GENE FOR PRIMARY BILIARY CIRRHOSIS IN JAPANESE PATIENTS
S. Joshita; T. Umemura; S. Morita; A. Kamijo; M. Komatsu; T. Ichijo; A. Matsumoto; K. Yoshizawa; E. Tanaka; M. Ota
JOURNAL OF HEPATOLOGY, 52(5), S425-S425, 2010, Not invited
Lead - A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
Satoru Joshita; Kaname Yoshizawa; Kenji Sano; Satoshi Kobayashi; Tomohiro Sekiguchi; Susumu Morita; Atsushi Kamijo; Michiharu Komatsu; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Eiji Tanaka
INTERNAL MEDICINE, 49(11), 991-994, 2010, Not invited
Lead - Association analysis of Toll-like receptor 4 polymorphisms with autoimmune pancreatitis
Takeji Umemura; Yoshihiko Katsuyama; Hideaki Hamano; Kei Kitahara; Mari Takayama; Norikazu Arakura; Shigeyuki Kawa; Eiji Tanaka; Masao Ota
HUMAN IMMUNOLOGY, 70(9), 742-746, Sep. 2009, Not invited
Lead - 【自己免疫性肝炎2009】 IgG4関連自己免疫性肝炎
梅村武司; 浜野英明; 一條哲也; 吉澤要; 田中榮司
肝・胆・膵, 59(1), 93-99, Jul. 2009, Not invited
Lead - 複数回治療後の再発性肝細胞癌の局所療法にソナゾイド^
造影超音波が有用であった1例
米田 傑; 城下 智; 一條 哲也; 上條 敦; 小松 通治; 梅村 武司; 松本 晶博; 吉澤 要; 田中 榮司
肝臓, 50(6), 250-256, May 2009, Not invited
Lead - Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection - Joint report of the Intractable Liver Diseases Study Group of Japan and the Japanese Study Group of the Standard Antiviral Therapy for Viral Hepa
Hirohito Tsubouchi; Hiromitsu Kumada; Kendo Kiyosawa; Satoshi Mochida; Isao Sakaida; Eiji Tanaka; Takafumi Ichida; Masashi Mizokami; Kazuyuki Suzuki; Shinsyo Yoshiba; Hisataka Moriwaki; Toshifumi Hibi; Norio Hayashi; Norihiro Kokudo; Tomoo Fujisawa; Hiromi Ishibashi; Yasuhiko Sugawara; Hiroshi Yatsuhashi; Akio Ido; Yasuhiro Takikawa; Kazuaki Inoue; Makoto Oketani; Hirofumi Uto; Nobuaki Nakayama; Takafumi Naiki; Shinichiro Tada; Shinichi Kiso; Koji Yano; Ryujin Endo; Yasuhito Tanaka; Takeji Umemura; Kotaro Kumagai
Acta Hepatologica Japonica, 50, 38-42, Feb. 2009, Not invited
Lead - A case of well-differentiated cholangiolocellular carcinoma visualized with contrast-enhanced ultrasonography using Sonazoid
Satoru Joshita; Tetsuya Ichijo; Fumitaka Suzuki; Takahide Yokoyama; Yukiko Sugiyama; Mana Fukushima; Atsushi Kamijo; Michiharu Komatsu; Takeji Umemura; Kaname Yoshizawa; Shinichi Miyagawa; Eiji Tanaka
HEPATOLOGY RESEARCH, 39(2), 207-212, Feb. 2009, Not invited
Lead - 免疫抑制・化学療法により発症するB型肝炎対策 : 厚生労働省「難治性の肝・胆道疾患に関する調査研究」班劇症肝炎分科会および「肝硬変を含めたウイルス性肝疾患の治療の標準化に関する研究」班合同報告
坪内 博仁; 熊田 博光; 清澤 研道; 持田 智; 坂井田 功; 田中 榮司; 市田 隆文; 溝上 雅史; 鈴木 一幸; 與芝 眞彰; 森脇 久隆; 日比 紀文; 林 紀夫; 國土 典宏; 藤澤 知雄; 石橋 大海; 菅原 寧彦; 八橋 弘; 井戸 章雄; 滝川 康裕; 井上 和明; 桶谷 真; 宇都 浩文; 中山 伸朗; 内木 隆文; 多田 慎一郎; 木曽 真一; 矢野 公士; 遠藤 龍人; 田中 靖人; 梅村 武司; 熊谷 公太郎
肝臓, 50(1), 38-42, Jan. 2009, Not invited
Lead - 広範囲の肝実質の脱落により奇異な肝形態を呈し自己免疫性肝炎が疑われた1例
城下 智; 一條 哲也; 吉澤 要; 福島 万奈; 小松 通治; 新井 薫; 田中 直樹; 梅村 武司; 松本 晶博; 田中 榮司
日本消化器内視鏡学会雑誌 = Gastroenterological endoscopy, 51(1), 48-54, Jan. 2009, Not invited
Lead - Epidemiology of hepatocellular carcinoma in Japan
Takeji Umemura; Tetsuya Ichijo; Kaname Yoshizawa; Eiji Tanaka; Kendo Kiyosawa
JOURNAL OF GASTROENTEROLOGY, 44, 102-107, Jan. 2009, Not invited
Lead - Pretreatment Prediction of Virological Response to Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients Using Viral and Host Factors
Shirakawa, Haruki; Matsumoto, Akihiro; Joshita, Satoru; Komatsu, Michiharu; Tanaka, Naoki; Umemura, Takeji; Ichijo, Tetsuya; Yoshizawa, Kaname; Kiyosawa, Kendo; Tuaka, Eiji; Nagano Interferon Treatment Res Gr
HEPATOLOGY, 48(6), 1753-1760, Dec. 2008
Lead - A GENOMEWIDE DNA MICROSATELLITE ASSOCIATION STUDY OF JAPANESE PATIENSTS WITH PRIMARY BILIARY CIRRHOSIS
Joshita, Satoru; Ota, Masao; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Ichijo, Tetsuya; Tanaka, Eiji
HEPATOLOGY, 48(4), 606A-606A, Oct. 2008
Lead - Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case.
Nagaya T; Tanaka N; Komatsu M; Ichijo T; Sano K; Horiuchi A; Joshita S; Umemura T; Matsumoto A; Yoshizawa K; Aoyama T; Kiyosawa K; Tanaka E
Clinical journal of gastroenterology, 1(3), 116-121, Oct. 2008, Refereed, Not invited
Lead - Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase
Naoki Tanaka; Tadanobu Nagaya; Michiharu Komatsu; Akira Horiuchi; Goro Tsuruta; Haruaki Shirakawa; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Toshifumi Aoyama; Kendo Kiyosawa; Eiji Tanaka
LIVER INTERNATIONAL, 28(8), 1104-1111, Sep. 2008, Not invited
Lead - Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan
Takeji Umemura; Eiji Tanaka; Kendo Kiyosawa; Hiromitsu Kumada
CLINICAL INFECTIOUS DISEASES, 47(5), E52-E56, Sep. 2008, Not invited
Lead - Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese
Takeji Umemura; Masao Ota; Kaname Yoshizawa; Yoshihiko Katsuyama; Tetsuya Ichijo; Eiji Tanaka; Kendo Kiyosawa
HEPATOLOGY RESEARCH, 38(7), 689-695, Jul. 2008, Not invited
Lead - Association of Autoimmune Pancreatitis With Cytotoxic T-lymphocyte Antigen 4 Gene Polymorphisms in Japanese Patients
Takeji Umemura; Masao Ota; Hideaki Hamano; Yoshihiko Katsuyama; Takashi Muraki; Norikazu Arakura; Shigeyuki Kawa; Kendo Kiyosawa
AMERICAN JOURNAL OF GASTROENTEROLOGY, 103(3), 588-594, Mar. 2008, Not invited
Lead - A Novel Immunoglobulin-Immunoglobulin Interaction in Autoimmunity
Shigeyuki Kawa; Kei Kitahara; Hideaki Hamano; Yayoi Ozaki; Norikazu Arakura; Kaname Yoshizawa; Takeji Umemura; Masao Ota; Sadaaki Mizoguchi; Yasunori Shimozuru; Seiamak Bahram
PLOS ONE, 3(2), -, Feb. 2008, Not invited
Lead - De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis
Yoshizawa, Kaname; Shirakawa, Haruaki; Ichijo, Tetsuya; Umemura, Takeji; Tanaka, Eiji; Kiyosawa, Kendo; Imagawa, Eri; Matsuda, Kazuyuki; Hidaka, Eiko; Sano, Kenji; Nakazawa, Yuichi; Ikegami, Toshihiko; Hashikura, Yasuhiko; Miyagawa, Shinichi; Ota, Masao; Nakano, Masayuki
CLINICAL TRANSPLANTATION, 22(3), 385-390-390, 2008, Not invited
Lead - Microsatellite scan identifies new candidate genes for susceptibility to alcoholic chronic pancreatitis in japanese patients
Kitahara K; Kawa S; Katsuyama Y; Umemura T; Ozaki Y; Takayama M; Arakura N; Ota M
Dis Markers, 25(3), 175-80-180, 2008, Not invited
Lead - 腹壁への浸潤が疑われ, 画像検査が診断の契機となった肝放線菌症の1例
武藤 英知; 一條 哲也; 小林 倫子; 田中 直樹; 梅村 武司; 小松 通治; 松本 晶博; 吉澤 要; 田中 榮司; 上田 和彦; 角谷 眞澄; 清澤 研道
肝臓 = ACTA HEPATOLOGICA JAPONICA, 48(11), 553-558, Nov. 2007, Not invited
Lead - Hepatitis B virus (HBV) reactivation in resolved HBV subjects in Japan
Umemura, Takeji; Kiyosawa, Kendo
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 22, A62-A62, Oct. 2007
Lead - 【自己免疫性膵炎】 自己免疫性膵炎の免疫遺伝学的解析
川茂幸; 浜野英明; 梅村武司; 太田正穂
BIO Clinica, 22(11), 963-967, Oct. 2007, Not invited
Lead - IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis
T. Umemura; Y. Zen; H. Hamano; T. Ichijo; S. Kawa; Y. Nakanuma; K. Kiyosawa
GUT, 56(10), 1471-1472, Oct. 2007, Not invited
Lead - Epidemiology of hepatocellular carcinoma in Japan
Takeji Umemura; Kendo Kiyosawa
HEPATOLOGY RESEARCH, 37(S2), S95-S100, Sep. 2007, Not invited
Lead - Immunoglobin G4-hepatopathy: Association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis
Takeji Umemura; Yoh Zen; Hideaki Hamano; Shigevuki Kawa; Yasuni Nakanuma; Kendo Kiyosawa
HEPATOLOGY, 46(2), 463-471, Aug. 2007, Not invited
Lead - Igg4-hepatopathy: Association of Igg4-bearing plasma cells in liver with autoimmune pancreatitis
Umemura, Takeji; Zen, Yoh; Hamano, Hideaki; Kawa, Shigeyuki; Nakanuma, Yasuni; Kiyosawa, Kendo
GASTROENTEROLOGY, 132(4), A45-A46, Apr. 2007
Lead - Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphism in Japanese patients
Umemura, Takeji; Ota, Masao; Hamano, Hideaki; Katsuyama, Yoshihko; Muraki, Takashi; Arakura, Norikazu; Kawa, Shigeyuki; Kiyosawa, Kendo
GASTROENTEROLOGY, 132(4), A464-A464, Apr. 2007, Not invited
Lead - Lack of association between FCRL3 and Fc gamma RII polymorphisms in Japanese type 1 autoimmune hepatitis
Takeji Umemura; Masao Ota; Kaname Yoshizawa; Yoshihiko Katsuyama; Tetsuya Ichijo; Eiji Tanaka; Shigeyuki Kawa; Kendo Kiyosawa
CLINICAL IMMUNOLOGY, 122(3), 338-342, Mar. 2007, Not invited
Lead - IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis
Hideaki Hamano; Takeji Umemura; Takeshi Uehara; Shigeyuki Kawa; Kendo Kiyosawa
AMERICAN JOURNAL OF GASTROENTEROLOGY, 102(3), 691-692, Mar. 2007, Not invited
Lead - A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1
Yokosawa, Shuichi; Yoshizawa, Kaname; Ota, Masao; Katsuyama, Yoshihiko; Kawa, Shigeyuki; Ichijo, Tetsuya; Umemura, Takeji; Tanaka, Eiji; Kiyosawa, Kendo
HEPATOLOGY, 45(2), 384-390, Feb. 2007
Lead - Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C
T. Umemura; H. Muto; E. Tanaka; A. Matsumoto; T. Ichijo; K. Yoshizawa; T. Akamatsu; K. Kiyosawa
JOURNAL OF VIRAL HEPATITIS, 14(1), 48-54, Jan. 2007, Not invited
Lead - Sclerosing Cholangitis Associated with Autoimmune Pancreatitis
Kawa S; Hamano H; Umemura T; Kiyosawa K; Uehara T
Hepatology Res, 37(Suppl3), 487-495-S495, 2007, Not invited
Lead - Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population
Naoki Tanaka; Eiji Tanaka; Yo Sheena; Michiharu Komatsu; Wataru Okiyama; Noriko Misawa; Hidetomo Muto; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Akira Horiuchi; Kendo Kiyosawa
LIVER INTERNATIONAL, 26(8), 956-963, Oct. 2006, Not invited
Lead - A genome-wide DNA microsatellite association study of autoimmune hepatitis type 1 in Japan
Kaname Yoshizawa; Shuichi Yokosawa; Masao Ota; Yoshihiko Katsuyama; Tetsuya Ichijo; Takeji Umemura; Akihiko Matsumoto; Eiji Tanaka; Kendo Kiyosawa
HEPATOLOGY, 44(4), 228A-228A, Oct. 2006, Not invited
Lead - Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy
Akinori Rokuhara; Akihiro Matsumoto; Eiji Tanaka; Takeji Umemura; Kaname Yoshizawa; Tatsuji Kimura; Noboru Maki; Kendo Kiyosawa
JOURNAL OF GASTROENTEROLOGY, 41(8), 785-790, Sep. 2006, Not invited
Lead - Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients
T. Umemura; M. Ota; H. Hamano; Y. Katsuyama; K. Kiyosawa; S. Kawa
GUT, 55(9), 1367-1368, Sep. 2006, Not invited
Lead - Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region
Kiyoshi Kitano; Hikaru Kobayashi; Mayu Hanamura; Kiyoshi Furuta; Mayumi Ueno; Akinori Rokuhara; Eiji Tanaka; Takeji Umemura; Kendo Kiyosawa
EUROPEAN JOURNAL OF HAEMATOLOGY, 77(3), 255-258, Sep. 2006, Not invited
Lead - Severe hepatic injury caused by orlistat
Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kendo Kiyosawa
AMERICAN JOURNAL OF MEDICINE, 119(8), E7-E7, Aug. 2006, Not invited
Lead - Quantitative analysis of anti-hepatitis C virus anti body-secreting B cells in patients with chronic hepatitis C
T Umemura; RYH Wang; C Schechterly; JWK Shih; K Kiyosawa; HJ Alter
HEPATOLOGY, 43(1), 91-99, Jan. 2006, Not invited
Lead - Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics
N Misawa; A Matsumoto; E Tanaka; A Rokuhara; K Yoshizawa; T Umemura; N Maki; T Kimura; K Kiyosawa
JOURNAL OF MEDICAL VIROLOGY, 78(1), 68-73, Jan. 2006, Not invited
Lead - Severe alcoholic hepatitis with extremely high neutrophil count successfully treated by granulocytapheresis
Okubo, Kentaro; Yoshizawa, Kaname; Okiyama, Wataru; Kontani, Kayoko; Muto, Hidetomo; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiko; Tanaka, Eiji; Hora, Kazuhiko; Shimodaira, Sigetaka; Kiyosawa, Kendo
INTERNAL MEDICINE, 45(3), 155-158, 2006
Lead - Fatal HBV reactivation in a subject with anti-HBs and anti-HBc
Umemura, Takeji; Kiyosawa, Kendo
INTERNAL MEDICINE, 45(12), 747-748, 2006
Lead - Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan
E Tanaka; A Matsumoto; N Takeda; TC Li; T Umemura; K Yoshizawa; Y Miyakawa; T Miyamura; K Kiyosawa
JOURNAL OF VIRAL HEPATITIS, 12(4), 439-442, Jul. 2005, Not invited
Lead - 当科における肝細胞癌に対するラジオ波焼灼術の実態
一條哲也; 沖山 洋; 武藤英知; 三沢倫子; 梅村武司; 松本晶博; 吉澤 要; 田中榮司; 清澤研道
長野県医学会雑誌, 35, 38-39, 2005, Not invited
Lead - Ethnicity affects the diagnostic validity of alpha-fetoprotein in hepatocellular carcinoma
Gad A; Tanaka E; Matsumoto A; Serwah Ael-H; Attia F; Hassan A; Ali K; Abbas A; el-Deeb Ael; Sun X; Umemura T; Ichijyo T; Ehara T; Yoshizawa K; Kiyosawa K
Asia-Pacific Journal of clinical oncology, 1, 64-70, 2005, Not invited
Lead - Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
Gad A; Tanaka E; Matsumoto A; Wahab MA; Serwah Ael-H; Attia F; Ali K; Hassouba H; el-Deeb Ael-R; Ichijyo T; Umemura T; Muto H; Yoshizawa K; Kiyosawa K
WorldJ Gastroenterol, 14(42), 6607-6612-6612, 2005, Not invited
Lead - Hepatocellular carcinoma: Recent trends in Japan
K Kiyosawa; T Umemura; T Ichijo; A Matsumoto; K Yoshizawa; A Gad; E Tanaka
GASTROENTEROLOGY, 127(5), S17-S26, Nov. 2004, Not invited
Lead - Wilson 病の治療と発症予防
梅村 武司; 田中 榮司; 清澤 研道
肝臓 = ACTA HEPATOLOGICA JAPONICA, 45(9), 459-462, Sep. 2004, Not invited
Lead - 我が国におけるSENウイルス感染の状況とその背景
梅村武司; 田中栄司
日本臨床, 62, 602-605, 2004, Not invited
Lead - SENウイルス(SEN V)の分子生物学
梅村武司; 田中栄司
日本臨床, 62, 596-597, 2004, Not invited
Lead - Prevalence of SEN viruses among injection drug users in the San Francisco Bay area
RM Pfeiffer; Y Tanaka; AET Yeo; T Umemura; KH Seal; JWK Shih; HJ Alter; BR Edlin; TR O'Brien
JOURNAL OF INFECTIOUS DISEASES, 188(1), 13-18, Jul. 2003, Not invited
Lead - Clinical significance of SEN virus infection in patients on maintenance haemodialysis
N Kobayashi; E Tanaka; T Umemura; A Matsumoto; T Iijima; M Higuchi; K Hora; K Kiyosawa
NEPHROLOGY DIALYSIS TRANSPLANTATION, 18(2), 348-352, Feb. 2003, Not invited
Lead - その他のウイルスによる肝炎
梅村武司; 田中榮司
臨床医, 29, 645-647, 2003, Not invited
Lead - Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis
Umemura, T; Tanaka, E; Ostapowicz, G; Brown, KE; Heringlake, S; Tassopoulos, NC; Wang, RYH; Yeo, AET; Shih, JWK; Orii, K; Young, NS; Hatzakis, A; Manns, MP; Lee, WM; Kiyosawa, K; Alter, HJ
JOURNAL OF INFECTIOUS DISEASES, 188(10), 1545-1552, 2003, Not invited
Lead - The role of SEN virus infection in various liver diseases from different geographical regions.
Umemura, T; Tanaka, E; Lee, WM; Ostapowicz, G; Heringlake, S; Manns, MP; Tasopoulos, NC; Hatzakis, A; Brown, KE; Young, NS; Wang, R; Yeo, A; Shih, J; Orii, K; Kiyosawa, K; Alter, HJ
HEPATOLOGY, 36(4), 646A-646A, 2002, Not invited
Lead - SEN virus: Response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C
Umemura, T; Alter, HJ; Tanaka, E; Orii, K; Yeo, AET; Shih, JWK; Matsumoto, A; Yoshizawa, K; Kiyosawa, K
HEPATOLOGY, 35(4), 953-959, 2002, Not invited
Lead - Observation of positive selection within hypervariable regions of a newly identified DNA virus (SEN virus)
Umemura, T; Tanaka, Y; Kiyosawa, K; Alter, HJ; Shih, JWK
FEBS LETTERS, 510(3), 171-174, 2002, Not invited
Lead - The evolutionary rate of SEN virus, a newly identified single-stranded circular DNA virus, is more similar to RNA viruses than classic DNA viruses.
T Umemura; Y Tanaka; K Kiyosawa; HJ Alter; JW Shih
HEPATOLOGY, 34(4), 636A-636A, Oct. 2001, Not invited
Lead - SEN virus infection in high- and non-endemic areas for hepatitis C in Japan.
T Umemura; HJ Alter; E Tanaka; AE Yeo; JW Shih; K Orii; A Matsumoto; K Yoshizawa; K Kiyosawa
HEPATOLOGY, 34(4), 487A-487A, Oct. 2001, Not invited
Lead - Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family.
Tanaka Y; Primi D; Wang RY; Umemura T; Yeo AE; Mizokami M; Alter HJ; Shih JW
The Journal of infectious diseases, 183(3), 359-367, Feb. 2001, Refereed, Not invited
Lead - A potential new hepatitis agent: Making SEN-se of the data
T. Umemura; A. E.T. Yeo; A. Sottini; D. Moratto; Y. Tanaka; R. Y.H. Wang; J. W.K. Shih; P. Donahue; D. Primi; H. J. Alter
Gastroenterology, 121, 734-735, Jan. 2001, Not invited
Lead - SEN virus infection and its relationship to transfusion-associated hepatitis
Umemura T, Yeo AET, Sottini A, Moratto A, Tanaka Y, Wang RYH, Shih JWK, Donahue P, Primi D, Alter HJ.
HEPATOLOGY, 33(5), 1303-1311, 2001, Not invited
Lead - Association between SENvirus infection and hepatitis C in Japan
Umemura, T; Alter, HJ; Tanaka, E; Yeo, AET; Shih, JWK; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K
JOURNAL OF INFECTIOUS DISEASES, 184(10), 1246-1251, 2001, Not invited
Lead - Genomic and molecular evolutionary analysis of a novel dna virus (sen virus) and relationship to variants of TT virus
Yasuhito Tanaka; Daniele Primi, Richard; Y. Wang; Takeji Umemura; Anthony E.T. Yeo; Masashi Mizokami; James W.K. Shih; Harvey J. Alter
Blood, 96, Dec. 2000, Not invited
Lead - The prevalence of SEN virus infection in Japanese patients with viral hepatitis and liver disease.
T Umemura; AE Yeo; Y Shih; A Matsumoto; K Orii; E Tanaka; K Kiyosawa; D Primi
HEPATOLOGY, 32(4), 381A-381A, Oct. 2000, Not invited
Lead - T cell repertoire in the liver of patients with primary biliary cirrhosis
H Inada; K Yoshizawa; M Ota; Y Katsuyama; T Ichijo; T Umemura; E Tanaka; K Kiyosawa
HUMAN IMMUNOLOGY, 61(7), 675-683, Jul. 2000, Not invited
Lead - Analysis of T cell repertoire in the liver of patients with chronic hepatitis C
Umemura, T; Yoshizawa, K; Ota, M; Katsuyama, Y; Inada, H; Tanaka, E; Kiyosawa, K
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 121(1), 120-126, 2000, Not invited
Lead - T cell repertoire in the liver of patients with autoimmune hepatitis
K Yoshizawa; M Ota; Y Katsuyama; T Ichijo; H Inada; T Umemura; E Tanaka; K Kiyosawa
HUMAN IMMUNOLOGY, 60(9), 806-815, Sep. 1999, Not invited
Lead - Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis
K Orii; E Tanaka; T Umemura; A Rokuhara; A Iijima; K Yoshizawa; H Imai; K Kiyosawa
HEPATOLOGY RESEARCH, 14(2), 161-170, Apr. 1999, Not invited
Lead - TT virus infection in an area of high-endemicity for hepatitis C
Umemura, T; Tanaka, E; Ota, M; Orii, K; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
HEPATOLOGY RESEARCH, 13(3), 212-220, 1999, Not invited
Lead - C型肝炎多発地域におけるTTV感染の疫学的検討
梅村武司
日本臨床, 57, 1397-1401, 1999, Not invited
Lead - TT virus infection in high- and non-endemicity areas for hepatitis C.
T Umemura; E Tanaha; K Orii; H Imai; K Yoshizawa; M Ota; K Kiyosawa
HEPATOLOGY, 28(4), 365A-365A, Oct. 1998, Not invited
Lead - Clinical performance of quantitative and highly sensitive HCV core antigen assay system.
E Tanaka; K Aoyagi; Y Nishizawa; T Umemura; K Orii; A Rokuhara; A Iijima; H Imai; K Yoshizawa; S Yagi; A Hasegawa; K Kiyosawa
HEPATOLOGY, 28(4), 279A-279A, Oct. 1998, Not invited
Lead - 胆嚢原発と考えられた悪性線維性組織球腫の1例 : 本邦報告例の検討
折井 幸司; 梅村 武司; 松沢 正浩; 吉江 崇宏; 田村 泰夫; 山村 伸吉; 飯島 義浩; 長田 敦夫; 代田 廣志; 中村 智次
日本消化器病學會雜誌 = The Japanese journal of gastro-enterology, 95(2), 161-166, Feb. 1998, Not invited
Lead - Case report: Steatonecrosis in the upper abdomen following transcatheter arterial embolization for hepatocellular carcinoma
Umemura, T; Yamamura, N; Nagata, A; Shibata, A; Yamashita, K; Ohata, T; Yamada, T; Katsuyama, T; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 13(5), 471-474, 1998, Not invited
Lead - 脾動脈塞栓術後脾摘を施行したHairy cell leukemiaの1例
梅村 武司; 森下 博史; 松沢 正浩; 折井 幸司; 高山 伸; 吉江 崇宏; 田村 泰夫; 飯島 義浩; 長田 敦夫; 大畑 武夫; 門馬 正志; 中村 智次; 林 正孝
信州医学雑誌, 45(1), 27-34, Feb. 1997, Not invited
Lead - 十二指腸水平部憩室からの出血に純エタノール局注療法が有効であった1例
梅村武司
Endosc Forum digest dis, 11, 237-241, 1995, Not invited
Lead
MISC
- 新たな脂肪性肝疾患の分類-年齢・性差からみた検討- MASLDにおける年齢、性別、病態ごとの肝関連イベント・心血管イベント発生率の検討
玉城 信治; 若林 俊一; 木村 岳史; 梅村 武司; 黒崎 雅之
日本高齢消化器病学会誌, 27(1), 44 - 44, Jul. 2024
Lead - B型肝炎診療Cutting edge B型肝炎既往感染者におけるiTACT-HBcrAgの臨床的有用性に関する検討
小林 浩幸; 城下 智; 梅村 武司
肝臓, 65(Suppl.1), A15 - A15, Apr. 2024
Lead - C型肝炎診療Cutting edge C型肝炎キャリア拾い上げにおいて,HCV抗体陽性者に対して残血清を用いたHCVコア抗原測定法併用の臨床的有用性
城下 智; 山下 裕騎; 梅村 武司
肝臓, 65(Suppl.1), A23 - A23, Apr. 2024
Lead - 肝硬変:基礎から臨床Cutting edge トロンボスポンジン2はMASLDにおける肝線維形成の重要な決定因子である
木村 岳史; 田中 直樹; 梅村 武司
肝臓, 65(Suppl.1), A41 - A41, Apr. 2024
Lead - 高齢社会における肝疾患の問題点 Vibration-controlled transient elastography(VCTE)は高齢の肝疾患患者の生命予後を予測できる
山下 裕騎; 木村 岳史; 梅村 武司
肝臓, 65(Suppl.1), A181 - A181, Apr. 2024
Lead - B型慢性肝炎における血清トロンボスポンジン2 核酸アナログ製剤治療中の量的変化と肝細胞癌発症リスク
奥村 太規; 木村 岳史; 岩垂 隆諒; 小林 浩幸; 若林 俊一; 山下 裕騎; 梅村 武司
肝臓, 65(Suppl.1), A368 - A368, Apr. 2024
Lead - ビッグデータを使用したLean MASLDの予後解析
若林 俊一; 玉城 信治; 木村 岳史; 梅村 武司; 黒崎 雅之
肝臓, 65(Suppl.1), A410 - A410, Apr. 2024
Lead - MASLDにおける肝発癌予測 血清オートタキシンの有用性
岩垂 隆諒; 木村 岳史; 奥村 太規; 若林 俊一; 小林 浩幸; 山下 裕騎; 梅村 武司
肝臓, 65(Suppl.1), A511 - A511, Apr. 2024
Lead - 当院での膵胆道癌に対するがん遺伝子パネル検査の現況
堀内 一太郎; 佐々木 信和; 南澤 昌郁; 鎌倉 雅人; 近藤 翔平; 柳澤 匠; 倉石 康弘; 中村 晃; 梅村 武司
長野県医学会雑誌, 54, 35 - 36, Mar. 2024
Lead - 最新の肝疾患の話題 ALT over 30のインパクト
梅村 武司
長野県医学会雑誌, 54, 80 - 80, Mar. 2024
Lead - 【自己免疫性肝疾患～病因,診断,治療～】自己免疫性肝疾患における非侵襲的肝線維化評価
山下 裕騎; 梅村 武司
Precision Medicine, 6(14), 1149 - 1151, Jan. 2024
Lead - C型肝炎キャリア拾い上げにおいて,HCV抗体陽性者に対して残血清を用いたHCVコア抗原測定法併用の臨床的有用性
城下 智; 山下 裕騎; 宇佐美 陽子; 岩垂 隆諒; 奥村 太規; 若林 俊一; 小林 浩幸; 杉浦 亜弓; 木村 岳史; 梅村 武司
肝臓, 64(12), 603 - 609, Dec. 2023
https://search.jamas.or.jp/default/link?pub_year=2023&ichushi_jid=J00263&link_issn=&doc_id=20231215170002&doc_link_id=10.2957%2Fkanzo.64.603&url=https%3A%2F%2Fdoi.org%2F10.2957%2Fkanzo.64.603&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif
Lead - 炎症性腸疾患に対する新規治療とバイオ治療再考 当院での潰瘍性大腸炎に対する分子標的薬の使用状況について
土屋 智章; 平山 敦大; 池内 浩志; 高 裕信; 澤口 洋視; 橋上 遣太; 岡村 卓磨; 岩谷 勇吾; 長屋 匡信; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 73回・95回, 41 - 41, Nov. 2023
Lead - 消化器疾患に対する低侵襲治療 85歳以上の超高齢肝腫瘍におけるアブレーション治療
山下 裕騎; 若林 俊一; 岩垂 隆諒; 奥村 太規; 小林 浩幸; 木村 岳史; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 73回・95回, 50 - 50, Nov. 2023
Lead - 経肛門的ダブルバルーン内視鏡を用いて電気水圧衝撃波結石破砕術で治療した胆石性イレウスの1例
木村 颯汰; 土屋 智章; 倉石 康弘; 中村 晃; 平山 敦大; 岡村 卓磨; 岩谷 勇吾; 長屋 匡信; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 73回・95回, 62 - 62, Nov. 2023
Lead - 当院における膵石症に対する体外衝撃波結石破砕療法を含めた内視鏡治療の治療成績と長期経過の検討
南澤 昌郁; 倉石 康弘; 佐々木 信和; 堀内 一太郎; 鎌倉 雅人; 近藤 翔平; 柳澤 匠; 中村 晃; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 73回・95回, 65 - 65, Nov. 2023
Lead - 当院における免疫関連有害事象(irAE)膵炎4例の検討
横山 岳; 近藤 翔平; 堀内 一太郎; 柳澤 匠; 鎌倉 雅人; 倉石 康弘; 中村 晃; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 73回・95回, 67 - 67, Nov. 2023
Lead - 血清オートタキシン値は骨髄線維症の診断マーカーになり得る
浅井 麻理子; 貝梅 紘子; 森田 貴裕; 松澤 周治; 川上 史裕; 川上 徹; 酒井 香生子; 酒井 均; 仁科 さやか; 五十嵐 浩二; 山崎 智生; 梅村 武司; 浅野 直子; 石田 文宏; 中澤 英之
日本血液学会学術集会, 85回, 552 - 552, Oct. 2023
Lead - Helicobacter pylori除菌によるバレット食道伸展についての検討
橋上 遣太; 岩谷 勇吾; 澤口 洋視; 原 大地; 宮澤 仁美; 宮澤 鷹幸; 平山 敦大; 岡村 卓磨; 長屋 匡信; 梅村 武司
Gastroenterological Endoscopy, 65(Suppl.2), 1972 - 1972, Oct. 2023
Lead - NAFLDにおけるトロンボスポンジン2 Bioinformaticsから導かれる肝線維化の新機軸
木村 岳史; 田中 直樹; 梅村 武司
日本消化器病学会雑誌, 120(臨増大会), A470 - A470, Oct. 2023
Lead - 肝胆膵希少疾患の診療体系の構築 自己免疫性膵炎における,オートタキシンの再燃予測マーカーとしての可能性
堀内 一太郎; 中村 晃; 梅村 武司
日本消化器病学会雑誌, 120(臨増大会), A656 - A656, Oct. 2023
Lead - 消化管領域における希少疾患に対する内視鏡診療 消化管トランスサイレチンアミロイドーシスの内視鏡像の検討
岡村 卓磨; 岩谷 勇吾; 梅村 武司
日本消化器病学会雑誌, 120(臨増大会), A703 - A703, Oct. 2023
Lead - 潰瘍性大腸炎における分子標的治療薬使用は血清LRGに影響するか
平山 敦大; 長屋 匡信; 澤口 洋視; 橋上 遣太; 原 大地; 宮澤 鷹幸; 宮澤 仁美; 岡村 卓磨; 岩谷 勇吾; 梅村 武司
日本消化器病学会雑誌, 120(臨増大会), A786 - A786, Oct. 2023
Lead - 膵胆管合流異常症における胆嚢,胆管のγH2AXを用いた背景粘膜障害の病理組織学的検討
鎌倉 雅人; 倉石 康弘; 中村 晃; 岩谷 勇吾; 長屋 匡信; 村木 崇; 上原 剛; 梅村 武司
日本消化器病学会雑誌, 120(臨増大会), A831 - A831, Oct. 2023
Lead - 消化器病疾患に携わる若手医師の魅力ある育成 臨床と基礎を繋ぐ トランスレーショナルな消化器内科医を目指す
木村 岳史; 梅村 武司
ENDOSCOPIC FORUM for digestive disease, 39(1), 31 - 31, Sep. 2023
Lead - 高齢者消化器病患者に対する治療戦略と課題 後期高齢者の食道表在癌に対する内視鏡的粘膜下層剥離術の現状と課題
宮澤 鷹幸; 岡村 卓磨; 岩谷 勇吾; 長屋 匡信; 梅村 武司
ENDOSCOPIC FORUM for digestive disease, 39(1), 43 - 43, Sep. 2023
Lead - 内視鏡診断が困難であった潰瘍性大腸炎関連進行癌の一例
武井 理紗; 平山 敦大; 澤口 洋視; 橋上 遣太; 原 大地; 宮澤 仁美; 宮澤 鷹幸; 岡村 卓磨; 岩谷 勇吾; 長屋 匡信; 北沢 将人; 山下 名帆; 岩谷 舞; 梅村 武司
ENDOSCOPIC FORUM for digestive disease, 39(1), 48 - 48, Sep. 2023
Lead - 主膵管断裂を伴う外傷性膵損傷、膵液瘻に対して内視鏡的膵管ドレナージが奏功した1例
関田 博昭; 近藤 翔平; 堀内 一太郎; 鎌倉 雅人; 柳澤 匠; 田中 友之; 中村 晃; 小口 貴也; 梅村 武司
ENDOSCOPIC FORUM for digestive disease, 39(1), 51 - 51, Sep. 2023
Lead - 多発する微小な褐色調陥凹性病変を呈した乳癌胃転移の1例
澤口 洋視; 橋上 遣太; 原 大地; 宮澤 仁美; 宮澤 鷹幸; 平山 敦大; 岡村 卓磨; 岩谷 勇吾; 長屋 匡信; 上原 剛; 梅村 武司
ENDOSCOPIC FORUM for digestive disease, 39(1), 52 - 52, Sep. 2023
Lead - NAFLDにおけるトロンボスポンジン2 Bioinformaticsから導かれる肝線維化の新機軸
木村 岳史; 田中 直樹; 梅村 武司
肝臓, 64(Suppl.2), A520 - A520, Sep. 2023
Lead - 肝硬変診療ガイドライン改訂に向けて 当科におけるCART治療の特徴についての検討
杉浦 亜弓; 城下 智; 梅村 武司
肝臓, 64(Suppl.2), A574 - A574, Sep. 2023
Lead - 高齢肥満者の血清学的な特徴とその課題
小林 浩幸; 城下 智; 梅村 武司
肝臓, 64(Suppl.2), A617 - A617, Sep. 2023
Lead - 機械学習による軽度線維化NASH拾い上げ診断能の検討
若林 俊一; 木村 岳史; 岩垂 隆諒; 奥村 太規; 小林 浩幸; 山下 裕騎; 杉浦 亜弓; 城下 智; 梅村 武司
肝臓, 64(Suppl.2), A618 - A618, Sep. 2023
Lead - NAFLDにおける肝関連イベント発生予測 血清オートタキシンの有用性
岩垂 隆諒; 木村 岳史; 奥村 太規; 若林 俊一; 小林 浩幸; 山下 裕騎; 杉浦 亜弓; 城下 智; 梅村 武司
肝臓, 64(Suppl.2), A619 - A619, Sep. 2023
Lead - 原発性胆汁性胆管炎(PBC)では治療介入後ALPをより低値にすると予後改善に寄与する
山下 裕騎; 城下 智; 岩垂 隆諒; 奥村 太規; 小林 浩幸; 若林 俊一; 杉浦 亜弓; 木村 岳史; 梅村 武司
肝臓, 64(Suppl.2), A641 - A641, Sep. 2023
Lead - 血清C-reactive protein値は切除不能肝細胞癌におけるレンバチニブ治療の予後予測に有用である 多施設共同研究
奥村 太規; 木村 岳史; 岩垂 隆諒; 小林 浩幸; 若林 俊一; 山下 裕騎; 杉浦 亜弓; 城下 智; 藤森 尚之; 國本 英雄; 小松 通治; 福島 秀樹; 森 宏光; 梅村 武司
肝臓, 64(Suppl.2), A647 - A647, Sep. 2023
Lead - HLA-G遺伝子多型とB型肝炎における疾患感受性、肝発癌、HBs抗原陰性化との関連
奥村 太規; 城下 智; 岩垂 隆諒; 若林 俊一; 小林 浩幸; 山下 裕騎; 木村 岳史; 太田 正穂; 梅村 武司
MHC: Major Histocompatibility Complex, 30(2Suppl.), 89 - 89, Sep. 2023
Lead - 【ウイルス性肝炎学2023-最新の病態・診断・治療情報-】B型肝炎 B型急性肝炎の動向 概論
小林 浩幸; 木村 岳史; 梅村 武司
日本臨床, 81(増刊7 ウイルス性肝炎学2023), 209 - 213, Jul. 2023
Lead - 【肝疾患-診療のチェックポイント2023】(第I部)診断のチェックポイント(第3章) 肝炎ウイルスマーカーのチェックポイント
梅村 武司
臨床消化器内科, 38(7), 771 - 773, Jun. 2023
Lead - IgG4関連疾患における診断・治療困難例に対する取り組み IgG4値の変動によるAIPの再燃予測の検討
堀内 一太郎; 中村 晃; 小口 貴也; 梅村 武司
日本消化器病学会甲信越支部例会抄録集, 72回, 40 - 40, Jun. 2023
Lead - 胆膵内視鏡検査・治療における工夫とトラブルシューティング 胆膵内視鏡検査におけるデクスメデトミジンの使用成績
近藤 翔平; 中村 晃; 小口 貴也; 梅村 武司
日本消化器病学会甲信越支部例会抄録集, 72回, 47 - 47, Jun. 2023
Lead - Klebsiella oxytocaにより侵襲性肝膿瘍症候群様の所見を呈した1例
武井 理紗; 岩垂 隆諒; 杉浦 亜弓; 奥村 太規; 若林 俊一; 鎌倉 雅人; 原 大地; 中村 晃; 木村 岳史; 梅村 武司
日本消化器病学会甲信越支部例会抄録集, 72回, 72 - 72, Jun. 2023
Lead - 小腸内視鏡による診断、治療の最前線(下部) 消化管原発濾胞性リンパ腫における小腸内視鏡の必要性についての検討
橋上 遣太; 長屋 匡信; 梅村 武司
Gastroenterological Endoscopy, 65(Suppl.1), 819 - 819, Apr. 2023
Lead - 希少疾患の内視鏡診断(全体) 消化管トランスサイレチンアミロイドーシスの内視鏡像の検討
岡村 卓磨; 岩谷 勇吾; 梅村 武司
Gastroenterological Endoscopy, 65(Suppl.1), 824 - 824, Apr. 2023
Lead - 内視鏡用新型デバイスデリバーシステムEndoSheatherを用いた経乳頭的胆管生検の検討
近藤 翔平; 中村 晃; 梅村 武司
Gastroenterological Endoscopy, 65(Suppl.1), 855 - 855, Apr. 2023
Lead - 肝移植後胆管吻合部狭窄に対するInside stentの有効性,安全性と至適留置期間について
鎌倉 雅人; 堀内 一太郎; 柳澤 匠; 近藤 翔平; 田中 友之; 中村 晃; 小口 貴也; 梅村 武司
Gastroenterological Endoscopy, 65(Suppl.1), 964 - 964, Apr. 2023
Lead - 肝硬変診療の未来予想図(現状と課題) 肝硬変におけるトロンボスポンジン2の臨床的意義 C型肝炎とNAFLDによる比較検討
木村 岳史; 田中 直樹; 梅村 武司
肝臓, 64(Suppl.1), A35 - A35, Apr. 2023
Lead - 高齢者肝疾患の現状と課題 後期高齢者におけるFIB-4 indexの分布とその特徴
小林 浩幸; 城下 智; 梅村 武司
肝臓, 64(Suppl.1), A124 - A124, Apr. 2023
Lead - 肝疾患と生活習慣 日常診療でNAFLD activity scoreを把握する surrogate markerの探索
木村 岳史; 田中 直樹; 梅村 武司
肝臓, 64(Suppl.1), A133 - A133, Apr. 2023
Lead - 肝疾患における有害事象をめぐる諸問題(薬物性肝障害を含めて) 薬物性肝障害とMac-2結合蛋白糖鎖修飾異性体に関する検討
山下 裕騎; 城下 智; 梅村 武司
肝臓, 64(Suppl.1), A210 - A210, Apr. 2023
Lead - 肝硬変の成因と病態の推移 長野県における肝硬変の成因別実態
山下 裕騎; 城下 智; 梅村 武司
肝臓, 64(Suppl.1), A257 - A257, Apr. 2023
Lead - B型慢性肝炎におけるHB表面抗原糖鎖異性体抗体の臨床的有用性
奥村 太規; 城下 智; 岩垂 隆諒; 小林 浩幸; 若林 俊一; 山下 裕騎; 杉浦 亜弓; 木村 岳史; 梅村 武司
肝臓, 64(Suppl.1), A422 - A422, Apr. 2023
Lead - 変分混合ガウス分布モデルを用いたNAFLDクラスタリングと予後との関連
若林 俊一; 木村 岳史; 岩垂 隆諒; 奥村 太規; 小林 浩幸; 山下 裕騎; 杉浦 亜弓; 城下 智; 梅村 武司
肝臓, 64(Suppl.1), A472 - A472, Apr. 2023
Lead - C型肝炎に対するDAA治療前後のALT変化率とSVR後の肝発癌との関連
杉浦 亜弓; 城下 智; 岩垂 隆諒; 奥村 太規; 小林 浩幸; 若林 俊一; 山下 裕騎; 木村 岳史; 梅村 武司
肝臓, 64(Suppl.1), A476 - A476, Apr. 2023
Lead - 血清トロンボスポンジン2はC型肝炎の病勢を反映する良いバイオマーカーである
岩垂 隆諒; 木村 岳史; 奥村 太規; 小林 浩幸; 若林 俊一; 山下 裕騎; 杉浦 亜弓; 城下 智; 梅村 武司
肝臓, 64(Suppl.1), A478 - A478, Apr. 2023
Lead - 機械学習によるNASH拾い上げ診断能の検討
若林 俊一; 木村 岳史; 岩垂 隆諒; 奥村 太規; 小林 浩幸; 山下 裕騎; 杉浦 亜弓; 城下 智; 梅村 武司
糖尿病, 66(Suppl.1), S - 324, Apr. 2023
Lead - 脂肪細胞の内在性Gq共役型受容体の活性化は全身の糖脂質代謝を改善する
木村 岳史; 田中 直樹; 梅村 武司
糖尿病, 66(Suppl.1), S - 324, Apr. 2023
Lead - 肝硬変に伴う肺高血圧症,肝肺症候群の診断と治療 慢性肝疾患患者における肺高血圧症症状と心エコー所見との関連
若林 俊一; 城下 智; 梅村 武司
日本消化器病学会雑誌, 120(臨増総会), A220 - A220, Mar. 2023
Lead - バレット食道表在癌とその背景粘膜に対するEMR単独群とRFA併用群の成績比較
岩谷 勇吾; 小林 亮介; 長屋 匡信; 岡村 卓磨; 平山 敦大; 梅村 武司
日本消化器病学会雑誌, 120(臨増総会), A298 - A298, Mar. 2023
Lead - NAFLD症例における軽度肝線維化マーカー FIB-4 indexは有用か
木村 岳史; 田中 直樹; 梅村 武司
日本消化器病学会雑誌, 120(臨増総会), A418 - A418, Mar. 2023
Lead - Direct acting antiviralsによるC型肝炎ウイルス排除がリポ蛋白(a)の量的変化に与える影響と遺伝子多型との関連についての検討
奥村 太規; 城下 智; 岩垂 隆諒; 小林 浩幸; 若林 俊一; 山下 裕騎; 杉浦 亜弓; 木村 岳史; 梅村 武司
日本消化器病学会雑誌, 120(臨増総会), A422 - A422, Mar. 2023
Lead - ステロイド反応性からみた自己免疫性膵炎の呼吸器病変
小松 雅宙; 山本 洋; 小沢 陽子; 和田 洋典; 北口 良晃; 牛木 淳人; 小口 貴也; 梅村 武司; 轟 圭介; 川上 聡; 藤永 康成; 上原 剛; 花岡 正幸
日本呼吸器学会誌, 12(増刊), 222 - 222, Mar. 2023
Lead - 当院における肝門部領域胆管癌に対する内視鏡的ドレナージ戦略
近藤 翔平; 中村 晃; 小口 貴也; 梅村 武司
ENDOSCOPIC FORUM for digestive disease, 38(2), 150 - 150, Dec. 2022
Lead - 反復性腸閉塞を契機に診断された回腸全周性管状絨毛腺腫の1例
上條 優真; 平山 敦大; 岡村 卓磨; 岩谷 勇吾; 長屋 匡信; 梅村 武司
ENDOSCOPIC FORUM for digestive disease, 38(2), 160 - 160, Dec. 2022
Lead - 消化器病疾患に携わる若手医師の魅力ある育成 臨床と基礎を繋ぐ トランスレーショナルな消化器内科医を目指す
木村 岳史; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 71回・93回, 28 - 28, Dec. 2022
Lead - 高齢者消化器病患者に対する治療戦略と課題 後期高齢者の食道表在癌に対する内視鏡的粘膜下層剥離術の現状と課題
宮澤 鷹幸; 岡村 卓磨; 岩谷 勇吾; 長屋 匡信; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 71回・93回, 43 - 43, Dec. 2022
Lead - 胃瘻交換時における側副血行路からの出血 経皮経肝閉塞術にて治療し得た稀な症例(Bleeding from collateral vessels during gastrostomy exchange: a rare case treated with percutaneous transhepatic occlusion)
奥村 太規; 木村 岳史; 宮澤 鷹幸; 塚原 嘉典; 長屋 匡信; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 71回・93回, 48 - 48, Dec. 2022
Lead - 内視鏡診断が困難であった潰瘍性大腸炎関連進行癌の一例
武井 理紗; 平山 敦大; 澤口 洋視; 橋上 遣太; 原 大地; 宮澤 仁美; 宮澤 鷹幸; 岡村 卓磨; 岩谷 勇吾; 長屋 匡信; 北沢 将人; 山下 名帆; 岩谷 舞; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 71回・93回, 55 - 55, Dec. 2022
Lead - 主膵管断裂を伴う外傷性膵損傷、膵液瘻に対して内視鏡的膵管ドレナージが奏功した1例
関田 博昭; 近藤 翔平; 堀内 一太郎; 鎌倉 雅人; 柳澤 匠; 田中 友之; 中村 晃; 小口 貴也; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 71回・93回, 58 - 58, Dec. 2022
Lead - 多発する微小な褪色調陥凹性病変を呈した乳癌胃転移の1例
澤口 洋視; 橋上 遣太; 原 大地; 宮澤 仁美; 宮澤 鷹幸; 平山 敦大; 岡村 卓磨; 岩谷 勇吾; 長屋 匡信; 上原 剛; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 71回・93回, 63 - 63, Dec. 2022
Lead - 原因不明の蛋白漏出性胃腸症に対し小腸切除が奏功した1例
木内 怜平; 宮澤 鷹幸; 堀内 一太郎; 澤口 洋視; 近藤 翔平; 杉浦 亜弓; 平山 敦大; 岡村 卓磨; 岩谷 勇吾; 長屋 匡信; 徳丸 重夫; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 71回・93回, 74 - 74, Dec. 2022
Lead - 原発性肺腺癌・IgG4関連疾患との鑑別を要した長期生存膵癌の1剖検例
岡 優祐; 若林 俊一; 木村 岳史; 中村 晃; 鎌倉 雅人; 平山 敦大; 成澤 友里; 岩谷 舞; 梅村 武司
日本消化器病学会甲信越支部例会・日本消化器内視鏡学会甲信越支部例会抄録集, 71回・93回, 80 - 80, Dec. 2022
Lead - 術後再建腸管に対するバルーン内視鏡下胆管結石治療の成績と採石困難な因子の検討
堀内 一太郎; 鎌倉 雅人; 近藤 翔平; 加古 里子; 田中 友之; 中村 晃; 小口 貴也; 梅村 武司
Gastroenterological Endoscopy, 64(Suppl.2), 2090 - 2090, Oct. 2022
Lead - 除菌後胃癌における組織学的リスク因子の検討
原 大地; 岡村 卓磨; 長屋 匡信; 橋上 遣太; 宮澤 鷹幸; 平山 敦大; 岩谷 勇吾; 梅村 武司
日本消化器病学会雑誌, 119(臨増大会), A740 - A740, Oct. 2022
Lead - 当院における胆管挿管困難例に対するプレカットの成績と今後の課題
田中 友之; 堀内 一太郎; 鎌倉 雅人; 近藤 翔平; 柳澤 匠; 中村 晃; 小口 貴也; 梅村 武司; 渡邉 貴之; 芦原 典宏
胆道, 36(3), 376 - 376, Sep. 2022
Lead - 自己免疫性肝疾患の病態解明と治療戦略 原発性胆汁性胆管炎の診断時ALBI grade 1症例における予後予測因子の検討
奥村 太規; 城下 智; 梅村 武司
肝臓, 63(Suppl.2), A513 - A513, Sep. 2022
Lead - 高齢者のDAA治療におけるSVR後肝癌および生命予後の検討
杉浦 亜弓; 城下 智; 奥村 太規; 若林 俊一; 小林 浩幸; 山下 裕騎; 木村 岳史; 梅村 武司
肝臓, 63(Suppl.2), A554 - A554, Sep. 2022
Lead - 慢性肝疾患における門脈圧亢進症性肺高血圧症のスクリーニングと実態
若林 俊一; 城下 智; 奥村 太規; 小林 浩幸; 山下 裕騎; 杉浦 亜弓; 山崎 智生; 木村 岳史; 梅村 武司
肝臓, 63(Suppl.2), A558 - A558, Sep. 2022
Lead - 2-Step PLT16-AST44法 NAFLDにおける簡便な肝線維化発見システムの有用性
木村 岳史; 田中 直樹; 梅村 武司
肝臓, 63(Suppl.2), A598 - A598, Sep. 2022
Lead - B型肝炎既往感染者の実態と肝線維化進展度との関連
小林 浩幸; 城下 智; 梅村 武司
肝臓, 63(Suppl.2), A604 - A604, Sep. 2022
Lead - NAFLDにおける肝線維化例囲い込み
藤森 尚之; 田中 直樹; 杉浦 亜弓; 山崎 智生; 城下 智; 梅村 武司; 松本 晶博; 田中 榮司
肝臓, 59(Suppl.2), A693 - A693, Sep. 2018, Not invited
Lead - Association of PTPN22 Haplotypes With Autoimmune Liver Disease in the Japanese Population
Tomoo Yamazaki; Satoru Joshita; Takeji Umemura; Eiji Tanaka; Masao Ota
GASTROENTEROLOGY, 150(4), S1058 - S1058, Apr. 2016, Not invited
Lead - Risk Factors for Long-term Persistence of Serum Hepatitis B Surface Antigen Following Acute Hepatitis B Virus Infection in Japanese Adults
Kiyoaki Ito; Hiroshi Yotsuyanagi; Hiroshi Yatsuhashi; Yoshiyasu Karino; Yasuhiro Takikawa; Takafumi Saito; Yasuji Arase; Fumio Imazeki; Masayuki Kurosaki; Takeji Umemura; Takafumi Ichida; Hidenori Toyoda; Masashi Yoneda; Eiji Mita; Kazuhide Yamamoto; Kojiro Michitaka; Tatsuji Maeshiro; Junko Tanuma; Yasuhito Tanaka; Masaya Sugiyama; Kazumoto Murata; Naohiko Masaki; Masashi Mizokami
HEPATOLOGY, 58, 617A - 618A, Oct. 2013, Not invited
Lead - Toll-like receptor 4とMyD 88がNAFLDの線維化に関連する
小松 通治; 田中 直樹; 長屋 匡信; 市川 雪; 木村 岳史; 森田 進; 城下 智; 梅村 武司; 松本 晶博; 田中 榮司
肝臓, 53(Suppl.1), A482 - A482, Apr. 2012, Not invited
Lead - Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers
Shiina T, Suzuki S, Ozaki Y, Taira H, Kikkawa E, Shigenari A, Oka A, Umemura T, Joshita S, Takahashi O, Hayashi Y, Paumen M, Katsuyama Y, Mitsunaga S, Ota M, Kulski JK, Inoko H
Tissue Antigens, 80(4), 305-16 - 16, 2012
Lead - ASSOCIATION ANALYSIS OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 4 GENE POLYMORPHISMS WITH PRIMARY BILIARY CIRRHOSIS IN JAPANESE PATIENTS
Satoru Joshita; Takeji Umemura; Kaname Yoshizawa; Yoshihiko Katsuyama; Sadahisa Okuhara; Yuki Ichikawa; Takefumi Kimura; Susumu Morita; Michiharu Komatsu; Tetsuya Ichijo; Akihiro Matsumoto; Masao Ota; Eiji Tanaka
HEPATOLOGY, 54, 1203A - 1203A, Oct. 2011, Not invited
Lead - HBeAgセロコンバージョン後のB型肝炎再燃とHBVマーカーとの関連
森田 進; 松本 晶博; 吉澤 要; 米田 傑; 上條 敦; 城下 智; 長屋 匡信; 小松 通治; 梅村 武司; 一條 哲也; 田中 榮司
日本消化器病学会雑誌, 107(臨増総会), A297 - A297, Mar. 2010, Not invited
Lead - C型慢性肝炎1b型高ウイルス量患者に対するペグインターフェロンとリバビリン併用療法の治療効果に与える宿主およびウイルス因子の影響
松本 晶博; 白川 晴章; 米沢 傑; 上條 敦; 長屋 匡信; 城下 智; 小松 通治; 田中 直樹; 梅村 武司; 一條 哲也; 吉澤 要; 太田 正穂; 勝山 善彦; 清澤 研道; 田中 榮司
肝臓, 50(Suppl.1), A131 - A131, Apr. 2009, Not invited
Lead - 原発性胆汁性肝硬変患者におけるゲノムワイドマイクロサテライト解析の検討
城下 智; 梅村 武司; 吉澤 要; 一條 哲也; 米田 傑; 上條 敦; 長屋 匡信; 小松 通治; 田中 直樹; 松本 晶博; 田中 榮司
肝臓, 50(Suppl.1), A162 - A162, Apr. 2009, Not invited
Lead - NASHでは線維化進行に伴いなぜ肝脂肪沈着が減少するのか 肝生検組織を用いた脂質代謝関連分子の発現解析
長屋 匡信; 田中 直樹; 上條 敦; 城下 智; 小松 通治; 梅村 武司; 一條 哲也; 松本 晶博; 吉澤 要; 田中 榮司
肝臓, 50(Suppl.1), A211 - A211, Apr. 2009, Not invited
Lead - C型慢性肝炎に対するペグインターフェロンα-2a+リバビリン併用療法の有効性・安全性に関する再治療例を含めた検討
松本 晶博; 宜保 行雄; 米田 傑; 上條 敦; 長屋 匡信; 城下 智; 小松 通治; 田中 直樹; 梅村 武司; 一條 哲也; 吉澤 要; 田中 榮司
肝臓, 50(Suppl.1), A349 - A349, Apr. 2009, Not invited
Lead - 造影超音波検査にて評価し得た高分化型細胆管癌の1例
城下 智; 一條 哲也; 小松 通治; 梅村 武司; 松本 晶博; 吉澤 要; 田中 榮司; 横山 隆秀; 宮川 眞一; 角谷 眞澄; 福島 万奈
肝胆膵治療研究会誌, 6(1), 109 - 109, Aug. 2008, Not invited
Lead - 肥満を伴わない非アルコール性脂肪肝疾患
田中 直樹; 小松 通治; 白川 晴章; 長屋 匡信; 城下 智; 小林 倫子; 新井 薫; 梅村 武司; 一條 哲也; 松本 晶博; 吉澤 要; 田中 榮司
長野県医学会雑誌, 38, 65 - 65, Mar. 2008, Not invited
Lead - 無再発生存期間から見た前向き検討による各種肝細胞癌腫瘍マーカーの意義
五十嵐 正人; 田村 康; 日浅 陽一; 恩地 森一; 梅村 武司; 田中 榮司; 柿崎 暁; 高木 均; 青柳 豊
肝臓, 48(Suppl.1), A276 - A276, Apr. 2007, Not invited
Lead - Two critical genes (HLA-DRB1 and ABCF1) in the HLA region are associated with the susceptibility to autoimmune pancreatitis
Masao Ota; Yoshihiko Katsuyama; Hideaki Hamano; Takeji Umemura; Akinori Kimura; Akinori Kimura; Kaname Yoshizawa; Kendo Kiyosawa; Hirofumi Fukushima; Seiamak Bahram; Hidetoshi Inoko; Shigeyuki Kawa
Immunogenetics, 59(1), 45 - 52, 01 Jan. 2007, Not invited
Lead
Books and other publications
- 今日の治療指針 私はこう治療している2022
梅村武司, Single work, 肝・胆・膵疾患
医学書院, 555-556 Jan. 2022臨床検査法提要改訂第35版
梅村武司, Single work, 消化機能検査 introduction
金原出版, 1475 May 2020臨床検査法提要改訂第35版
梅村武司, Single work, 消化機能検査 肝・胆道機能検査
金原出版, 1475 May 2020IgG4関連疾患 改定第2版
梅村武司, Single work, 臓器別病変の診断と治療 肝病変 治療と予後
株式会社診断と治療社, 130 Dec. 2019IgG4関連疾患 改定第2版
梅村武司, Single work, 臓器別病変の診断と治療 肝病変 検査・診断
株式会社診断と治療社, 128-129 Dec. 2019IgG4関連疾患 改定第2版
梅村武司, Single work, 臓器別病変の診断と治療 肝病変 病態
株式会社診断と治療社, 126-127 Dec. 2019肝硬変の成因別実態
杉浦亜弓, 城下智, 髙橋芳之, 栗林直矢, 山崎智生, 藤森尚之, 梅村武司, 松本晶博, 田中榮司, Single work, 長野県における肝硬変の成因実態
医学図書出版, 80-81 Mar. 2019ナースのための肝炎看護ハンドブック改訂版
梅村武司, Single work, C型肝炎ウイルスの減菌・消毒
医療ジャーナル社, 72-80 Sep. 2016ナースのための肝炎看護ハンドブック改訂版
梅村武司, Single work, 針刺し事故の予防および対策
医療ジャーナル社, 61-71 Sep. 2016最新・C型肝炎経口薬治療マニュアル
梅村武司, Single work, 腎機能障害症例、透析症例
診断と治療社, 60-61 Apr. 2016リウマチ・膠原病診療ハイグレード リウマチ・膠原病の合併症や諸問題を解く
梅村武司, Single work, ウイルス性肝炎や肝障害を認めたらどう対処すべきか？
文光堂, 274-283 Jan. 2016Lectures, oral presentations, etc.
- C型肝炎に対するDAA治療によるウイルス学的著効が肝機能と肝線維化改善に与える臨床的影響
杉浦亜弓, 城下智, 梅村武司
第43回日本肝臓学会東部会, Dec. 2020直接作用型抗ウイルス剤によるHCV排除が脂質代謝系および脂質プロファイルの量的変動と質的変動に与える影響
城下智, 山下裕騎, 梅村武司
第43回日本肝臓学会東部会, Dec. 2020内科治療抵抗性のシャント型肝性脳症に対してB-RTOを施行した3症例の検討
若林俊一, 山崎智生, 小林浩幸, 山下裕騎, 杉浦亜弓, 城下智, 梅村武司
第43回日本肝臓学会東部会, Dec. 2020予後・病型・成因ごとにみた急性肝不全におけるM2BPGiの臨床的意義の検討
山崎智生, 城下智, 梅村武司
第43回日本肝臓学会東部会, Dec. 2020肝原発MALT（Mucosa-Associated Lymphoid Tissue）リンパ腫を合併したB型肝炎無症候性キャリアの１例
山下裕騎, 城下智, 梅村武司
第43回日本肝臓学会東部会, Dec. 2020PBC(Primary biliary cholangitis)患者の骨密度低下拾い上げにおける骨粗鬆症関連マーカーの臨床的有用性について
山下裕騎, 城下智, 梅村武司
第43回日本肝臓学会東部会, Dec. 2020C型肝炎に対するDAA治療によるウイルス学的著効が肝機能と肝線維化改善に与える臨床的影響
杉浦亜弓、城下智、山下裕騎、山崎智生、藤森尚之、梅村武司
第56回 日本肝癌研究会, Dec. 2020実臨床における核酸アナログ等未介入例・核酸アナログ治療例・ドラックフリー例のB型肝炎の臨床的特徴と実態
城下智、松本晶博、梅村武司
第56回 日本肝癌研究会, Dec. 2020M2BPGiおよびAutotaxinは薬物性肝障害における組織学的炎症を反映し得るか
山崎智生、城下智、梅村武司
第56回 日本肝癌研究会, Dec. 2020原発性胆汁性胆管炎(PBC)における初診時生化学的検査所見と予後予測式が予測する予後との関連
山下裕騎、城下智、梅村武司
第56回 日本肝癌研究会, Dec. 2020原発性胆汁性胆管炎の急激な病状悪化の原因がE型肝炎ウイルスの急性感染であった１剖検例
小山みずき、山崎智生、山下裕騎、杉浦亜弓、藤森尚之、城下智、 梅村武司、岡本宏明
第56回 日本肝癌研究会, Dec. 2020進行肝細胞癌に対する分子標的薬治 療患者の臨床的特徴とシーケンシヤル療法の有用性
城下智, 山下裕騎, 杉浦亜弓, 山崎智生, 梅村武司
第56回 日本肝癌研究会, Dec. 2020胆嚢管の壁肥厚初見に対して、どのようにアプローチすべきか？
加古里子、田中友之、芦原典宏、倉石康弘、渡邉貴之、梅村武司
日本消化器病学会第67回甲信越支部例会日本消化器内視鏡学会第90回甲信越支部例会, Nov. 2020肝類洞閉塞症候群様の病態で発症した肝アミロイドーシスの一剖検例
土屋智章、杉浦亜弓、山下裕騎、山崎智生、城下智、梅村武司
第67回日本消化器病学会甲信越支部例会, Nov. 2020超音波内視鏡で膵管壁肥厚様所見を認めた自己免疫性膵炎の1例
清水祐樹、田中友之、加古里子、芦原典宏、倉石康弘、渡邉貴之、梅村武司
第67回日本消化器病学会甲信越支部例会, Nov. 2020⾃⼰免疫性膵炎とIgG4関連硬化性胆管炎に合併する縦隔・肺⾨リンパ節腫⼤の臨床的意義に関する検討
倉石康弘, 渡邉貴之, 梅村武司
JDDW2020, Nov. 2020C型肝炎に対するDAA治療後M2BPGi低値群のSVR後肝発癌症例の臨床的特徴
杉浦亜弓, 城下智, 山下裕騎, 山崎智生, 梅村武司
JDDW2020, Nov. 2020DAA治療によるHCV排除はHDL-Cの量的変動のみならず，質的な変動にも関与する
城下智, 杉浦亜弓, 梅村武司
JDDW2020, Nov. 2020PBCにおける脂質異常症とLOX-1との関連
山下裕騎, 城下智, 梅村武司
JDDW2020, Nov. 2020内視鏡的胆汁逆流所見はバレット食道の独立した関連因子である
岩谷勇吾, 長屋匡信, 梅村武司
JDDW2020, Nov. 2020ペマフィブラートが奏功した,小児期発症AIHの加療中にPBCと高TG血症を合併した1例
高裕信、山下裕騎、山崎智生、小林浩幸、若林俊一、杉浦亜弓、城下智、梅村武司
第147回日本内科学会信越地方会, Oct. 2020自己免疫性肝炎の病態に関連するkiller cell immunoglobulin-like receptors(KIR)/HLAの役割についての検討
梅村武司、城下智、齋藤博美
第106回日本消化器病学会総会, Aug. 2020ALT正常C型慢性肝炎患者に対して全例「ウイルス排除」に向けた直接作用型抗ウイルス剤治療の臨床的意義
城下智、杉浦亜弓、梅村武司
第106回日本消化器病学会総会, Aug. 2020非慢性膵炎例における膵外分泌機能の検討
芦原典宏、金井圭太、渡邉貴之、加古里子、倉石康弘、小澤真希子、梅村武司
第106回日本消化器病学会総会, Aug. 2020原発性胆汁性胆管炎の非侵襲的病期診断法の臨床的有用性
城下智、山下裕騎、杉浦亜弓、山崎智生、梅村武司
第117 回日本内科学会総会・講演会, Aug. 2020C型肝炎に対するDAA治療における経時的なM2BPGi測定の臨床的意義とSVR後肝発癌との関連
杉浦亜弓、城下智、梅村武司、高橋芳之、栗林直矢、山崎智生、藤森尚之、松本晶博、田中榮司
JDDW2019, Nov. 2019薬物性肝障害における肝病理学的検討の意義
山崎智生, 城下智1, 梅村武司
JDDW2019, Nov. 2019嚢胞性肝転移を呈し腎細胞癌術後9年目に肝切除を施行した一例
清水祐樹、杉浦亜弓、城下智、山下裕騎、山崎智生、藤森尚之、梅村武司、上原剛、清水明、副島雄二
第65回日本消化器病学会甲信越支部例会, Nov. 2019C型慢性肝炎のDAA治療におけるVCTE™の臨床的特徴の検討
杉浦亜弓、城下智、山下裕騎、山崎智生、藤森尚之、松本晶博、梅村武司
日本超音波医学会第31 回関東甲信越地方会学術集会, Oct. 2019内科治療抵抗性の門脈大循環シャント関連肝性脳症に対しB-RTO が著効した1 例
畔上周子、山崎智生、山下裕騎、杉浦亜弓、藤森尚之、城下智、梅村武司、深松史聡、黒住昌弘、藤永康成
第145回日本内科学会信越地方会, Oct. 2019発作性心房細動に対するカテーテルアブレーション後に生じた消化管蠕動障害の1例
小林克己、芦原典宏、加古里子、倉石康弘、小澤真希子、金井圭太、渡邉貴之、梅村武司、吉江幸司
第145回日本内科学会信越地方会, Oct. 2019炎症性腸疾患の病型に関わるKIR-HLAペアリング効果
鈴木宏、城下智、杉浦亜弓、齋藤博美、平山敦大、赤羽由紀、山崎麻美、勝山善彦、梅村武司、太田正穂
第28回日本組織適合性学会大会, Sep. 2019KIR/HLAは自己免疫性肝炎の疾患感受性、病態進展と関連する
梅村武司、城下智、赤羽由紀、山崎麻美、勝山善彦、太田正穂
第28回日本組織適合性学会大会, Sep. 2019血小板増多を呈する脾腫を契機に骨髄増殖性腫瘍の診断に至った１症例
城下智、仁科さやか、山下裕騎、梅村武司
第26回日本門脈圧亢進症学会総会, Sep. 2019腎機能障害と肝硬変患者の予後の関連性についての後方視的解析
山下裕騎、梅村武司、城下智、髙橋芳之、杉浦亜弓、山崎智生、藤森尚之、松本晶博
第26回日本門脈圧亢進症学会総会, Sep. 2019長野県におけるC型慢性肝炎に対する直接作用型抗ウイルス剤治療の実臨床における成績と課題
杉浦亜弓、城下智、山下裕騎、髙橋芳之、山崎智生、藤森尚之、松本晶博、梅村武司
第70回長野県医学会, Jul. 2019直接作用型抗ウイルス剤治療によるC型肝炎ウイルス排除が脂質変動と脂質判定区分の変化に与える影響
城下智、梅村武司、田中榮司
第60 回日本人間ドック学会学術大会, Jul. 2019PersistentlyNormalALTC型慢性肝炎がDAA治療後の肝発癌に与える影響
城下智、杉浦亜弓、梅村武司
第55回日本肝癌研究会, Jul. 2019興味深い画像所見を呈した通常型膵癌の1例
平林正裕、小澤真希子、加古里子、芦原典宏、倉石康弘、金井圭太、渡邉貴之、梅村武司
第86回 日本消化器内視鏡学会甲信越支部例会, Jun. 2019赤痢アメーバ特異的PCR法が陽性であったアメ ーバ性肝膿瘍の 1例
小山みずき、杉浦亜弓、城下智、高橋芳之、栗林直矢、山崎智生、藤森尚之、堀内一樹、松本剛、梅村武司
第64回 日本消化器病学会甲信越支部例会, Jun. 2019当院における急性肝不全，慢性肝不全，Acute-On-Chronic-Liver Failure症例の予後因子に関する検討
髙橋芳之、城下智、梅村武司
第55回日本肝臓学会総会, May 2019クローン病の寛解期にサイトメガロウィルス肝炎を発症した1例
南澤昌郁、山崎智生、城下智、高橋芳之、栗林直矢、杉浦亜弓、藤森尚之、梅村武司、松本晶博、田中榮司
第55回日本肝臓学会総会, May 2019C型慢性肝炎におけるDAAs難治例の臨床的特徴についての検討
杉浦亜弓、城下智、梅村武司
第55回日本肝臓学会総会, May 2019Persistently Normal ALT C 型慢性肝炎における Direct Acting Antivirals 療法の臨床的特徴と実態
城下智、杉浦亜弓、梅村武司
第55回日本肝臓学会総会, May 2019原発性胆汁性胆管炎の肝硬変進展に関する予後予測式の有効性
城下智、山下裕騎、梅村武司
第55回日本肝臓学会総会, May 2019当科におけるHBV再活性化および核酸アナログ予防内服の検討
山崎智生、城下智、梅村武司
第55回日本肝臓学会総会, May 2019実臨床におけるグレカプレビル/ピブレンタスビル治療の有用性と再治療例の臨床的特徴
杉浦亜弓、城下智、梅村武司、髙橋芳之、栗林直矢、山崎智生、藤森尚之、松本晶博、田中榮司
第105回日本消化器病学会総会, May 2019C型慢性肝炎におけるDAA治療failureの予測因子の検討
梅村武司、山崎智生、城下智
第105回日本消化器病学会総会, May 2019慢性肝疾患におけるATX およびM2BPGi の非侵襲的病期診断マーカーとしての有用性とその臨床的意義
城下智、梅村武司、田中榮司
第105回日本消化器病学会総会, May 2019C型肝炎におけるPNALT症例の特徴とDAAs治療の意義
城下智、杉浦亜弓、梅村武司、田中榮司
第116回日本内科学会総会・講演会, Apr. 2019Research Themes
- 肝線維化の機序解明と評価法の確立および治療法の開発
肝炎等克服実用化研究事業 肝炎等克服緊急対策研究事業, 国立研究開発法人日本医療研究開発機構
信州大学
2023 - Nucleotide analog製剤の宿主免疫賦活機能を利用してB型肝炎のHBs抗原消失向上を目指す治療法の開発および創薬に関する研究
肝炎等克服実用化研究事業 肝炎等克服緊急対策研究事業, 国立研究開発法人日本医療研究開発機構
信州大学
2022 - 2024 - 自己免疫性肝疾患におけるHLA-KIR遺伝子多様性の解析と病態解明
科学研究費助成事業, 日本学術振興会, 基盤研究(C)
信州大学
01 Apr. 2020 - 31 Mar. 2023 - Analysis of disease specific T cell receptors in autoimmune liver diseases
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C)
Shinshu University
01 Apr. 2017 - 31 Mar. 2020 - Whole-exome sequencing identifies a novel genetic susceptibility locus in autoimmune liver diseases
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C)
Shinshu University
01 Apr. 2014 - 31 Mar. 2017 - Resequencing of the entire HLA region in autoimmune liver diseases
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C)
Shinshu University
2011 - 2013 - Comprehensive analysis of the relationship between gene polymorphisms and protein expression and pathology, therapeutic value and prognosis of autoimmune liver diseases.
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C)
Shinshu University
2010 - 2012 - C型肝炎ウイルス抗体産生B細胞の定量とその臨床的意義の解明
科学研究費助成事業, 日本学術振興会, 若手研究(B)
信州大学
2006 - 2008
